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Abstract
Daniel Kirby - Centrifugal Magnetophoresis
Cancer is one of the primary causes of death and long-term illness in
the developed world. Early detection before noticeable symptoms appear,
or cheap options for population screening and ongoing patient analysis are
equally as important as advancements in treatment.
Currently, cancer detection and prognosis happens for the most part via
a scan or biopsy. If this information could instead be obtained from a simple
blood sample the world of cancer treatment and detection would be revo-
lutionised. To that end, this thesis outlines the work undertaken towards
completion of a PhD on the topic of magnetophoretic cell handling on a cen-
trifugal microfluidic platform for rare cancer cell detection in blood. This
resulted in first using “bio-mimetic” microbeads to prove the physical princi-
ple and then using magnetically tagged MCF7 breast cancer cells spiked into
a blood sample to simulate circulating tumour cells (CTC’s). This strategy
proved successful and resulted in detecting magnetically tagged cancer cells
in a blood background at a concentration of as low as 1 cell/µl and with a
sensitivity of over 80%.
On completion of this phase in the research, the usability of the device
using patient blood samples was investigated through a collaboration with
pathologists at St. James’ Hospital, Dublin. The first step in this phase was
to redesign the system to process clinically relevant volumes which, due to
the rarity of CTC’s in the circulatory system, were on the millilitre scale, as
opposed to the microlitre scale. After the redesign it was now possible to
successfully analyse 0.2ml of blood and detect cancer cells at a concentration
of as low as 0.1 cells/µl.
As well as focusing on the main topic, the author has also investigated
various other methods of magnetic and stopped flow particle control for other
purposes and all of these also-explored areas of stopped-flow microfluidics fit
in well with the broader picture of creating low-cost, easy to use lab-on-a-
disc technologies that utilise stopped-flow microfluidic systems and magnetic
forces to enable detection of specific cells in blood.
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Chapter 1
General Introduction
1.1 Motivation
For a disease which will effect one in three people at some stage in their life
[1], cancer diagnosis has yet to leverage many of the advances made in the
most modern of newer engineering and microfluidic technologies. Diagnosis
often happens when the patient’s cancer is already significantly advanced,
despite the fact that time is one of the major factors in determining a pa-
tient’s outcome. This diagnosis is also typically performed at a very large
cost of both capital equipment and man-power. The possibility of reduc-
ing costs, reducing waiting times and enabling earlier detection of cancer by
creating a method of detecting circulating tumour cells (CTC’s) in a blood
sample has been a goal of biomedical research for quite a long time. However,
the isolation and identification of unique biological cells of interest from a
large population of background blood cells remains a challenge in biomedical
diagnostics and analysis [2–5]. CTC’s may be present in concentrations of
anywhere from one cell to a several thousand cells in a few mililiters of blood
[6–8]. If the current hurdles to creating a point-of-care CTC detection device
can be overcome there is an obvious application potential towards cancer
screening and treatment [5, 9]. To that end, a lab-on-a-disc magnetophoretic
device to detect the presence of CTC’s was envisaged.
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The initial concept of on-disc magnetophoresis for particle separation was
presented in the conference proceedings of MEMS 2011 [10] and MicroTAS
2011 [11] by Siegrist et al.. Based on the success of this work, it was proposed
that a device that could utilise the strengths of lab-on-a-disc magnetophoretic
technology could be used to detect circulating tumour cells in a blood sample,
and the advancement of this concept towards fruition is presented in the
upcoming chapters of this document. Credit must be given to Jonathan
Siegrist for initial work done on chapter two, in tandem with the author.
1.2 Cancer diagnostics
The field of cancer diagnostics has been at the forefront of biomedical re-
search for many years and is a constant focus of new diagnostic devices and
technologies. Currently, the most common way for a patient to be diagnosed
with cancer of any type is to present to a doctor with physical symptoms.
A positive diagnosis is usually only confirmed by either a biopsy or a scan,
both of which are invasive and costly procedures (usually with long wait-
ing lists) which often only diagnose the cancer too late to enable successful
treatment. These procedures also require highly trained clinicians and tech-
nicians, which adds to the cost and time constraints accrued. A more recent
addition to the cancer diagnostics field has been the area of circulating tu-
mour cell detection. Circulating tumour cells have been known to exist since
the late 1800s [12] and their responsibility for spreading cancer throughout
the body via the circulatory system and causing metastases has been high-
lighted many times [13–15]. However, due to their incredibly high rarity in
the blood [7, 8, 16], CTCs have not been accessible for diagnosis or prognosis
until the advent of the Cellsearch system (Cellsearch, Veridax) in 2004, still
the only FDA approved system for CTC detection. As well as costing many
hundreds of thousands of dollars, the Cellsearch system has been shown to
be very limited in its ability to reliably find and detect CTCs [16, 17]. There
is therefore a gap in the market to develop a more reliable and financially
agreeable CTC detection system that doesn’t require a team of highly trained
staff and a high-tech laboratory environment. If a patient could have a blood
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sample taken and analysed in a point-of-care device in their doctor’s office
to show the presence of CTC’s, then precious time and resources could be
saved. Screening of the general public would be a far more realistic possibil-
ity and treatment outcomes could be determined by a blood sample. This
would revolutionise cancer treatment.
1.3 The lab-on-a-disc platform
The field of centrifugal microfluidic or “lab-on-a-disc” platforms has been
growing significantly in recent years and Ducre´e, Burger, Stroheimer and
Gorkin have all published excellent review articles on the topic [18–21]. The
lab-on-a-disc platform enables liquids and particles to be controlled by the
centrifugal force which is created by rotating the platform at the desired
speed. The centrifugal force is a pseudo force that acts outwards from centre
to edge from the frame of reference of the rotating disc [18].
While there have been numerous novel publications in the field of lab-on-
a-disc platforms [18, 21, 22], this work focuses on the area of cell and particle
control. The many advantages of the lab-on-a-disc platform for cell/particle
analysis include precise control of sedimentation rates of cells or particles in
liquid suspension by merely varying the centrifugal force through control of
the rotation speed of the disc. The review by Burger et al. [19] focuses on
this area in particular.
To enable rotation and visualisation of the microfluidic discs, a “spin-
stand” instrument was used that allowed visualisation during rotation by
means of a strobe light timed to the motor and optical setup [23] (Fig. 1.1).
This setup allowed for real time video of particle trajectories on the cel-
lular level to be captured, which enabled a thorough analysis of cells or
biomimetic polystyrene microparticles as they passed through the various
microchannels on-disc. This process is outlined in greater detail along with
an analysis of the various forces present for biomimetic particles in chapter
two, while chapter three deals with advancing the work to enable using real
cancer cells and blood on the platform.
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Figure 1.1: Schematic of the basic concept of the spin-stand. As the lab-on-
a-disc platform spins, a strobe light is triggered once every rotation which
allows the optical setup to obtain an image of the area under illumination.
This enables real time visualisation of the disc during rotation.
1.4 Stopped-flow microfluidics
All microfluidic systems in this body of work are based on “stopped-flow
microfluidics”. Stopped-flow microfluidics consists of a microchannel filled
with a stationary carrier fluid, through which particles or cells are sedimented
by an external force.
This force could be gravity or the magnetic force. However, a unique ad-
vantage of centrifugal microfluidics is the fact that this force can be delivered
and precisely controlled via the “artifical gravity” of the centrifugal force.
This area of stopped-flow microfluidics on a centrifugal platform is almost
completely unexplored. There are no papers more than ten years old in the
literature on this topic. The first mention of a stopped flow system on a cen-
trifugal platform is by Grumman et al.[25] and the only other published work
which covered the area since then was by Burger et al. [24, 26, 27]. When
trying to create new diagnostic platforms that analyse cells, bacteria, or any
particulates that will sediment in a liquid, the stopped-flow centrifugal mi-
crofluidic platform offers many unique advantages (Fig. 1.2). These include,
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Figure 1.2: A comparison of the behaviour of a particle in a pressure driven
flow-based system (left) and centrifugal stopped-flow system (right). a) A
particle travelling in a moving liquid (due to a pressure difference ∆P ) from
a narrow channel into a wide channel will undergo a changing velocity profile
depending on the channel width and will also follow the flow lines towards
the centre of the channel (Comsol, USA). b) Whereas a particle sedimenting
through a stationary fluid via the Centrifugal force (Fω) will travel radially
outwards, unaffected by the channel geometry. c) A flow-based system will
cause most particles to follow the flow lines and travel around obstacles like
the ones shown here [24]. d) Whereas in a stopped-flow system there are no
flow lines and particles will merely sediment in a radially outward direction
irrespective of any obstacles in their path [24].
but are not limited to, highly ordered particle motion (a unobstructed par-
ticle with a density greater than the liquid suspension will merely sediment
radially outward in a straight line), precise velocity control by controlling spin
rate, low-shear transport of cells due to the absence of fluid flow, uniform
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velocity across a channel (parabolic flow profiles are not present), unique
interaction parameters with obstacles in a chamber fig1.2 c& d , varying sed-
imentation rates depending on particle size and density for sorting purposes
etc. etc.
While there are certainly caveats associated with stopped-flow microflu-
idics such as limitations on sample volume and loading difficulties (see chap-
ter 5.2.4), it is an area of microfluidic research that should be thoroughly
investigated to enable the exploitation of its unique parameters to create
novel biomedical devices that will advance the field of lab-on-a-chip and
point-of-care technologies.
1.5 Magnetic Particle Control
The majority of work presented in this thesis concerns the magnetic control
of micro-particles or magnetically tagged cells on a rotating microfluidic plat-
form. The field of magnetic particle control has been around for quite some
time and has been reviewed extensively by Gijs et al. [28, 29] and Pamme et
al. [4] and a very thorough and in depth analysis of all aspects of magnetic
particle control, including particle manufacturing, an analysis of all forces
present and a range of different magnetic particle handling platforms present
in the literature can be found therein. These particles are also referred to
as “beads” due to their spherical nature. The forces governing the motion
of these magnetic (and non-magnetic) beads are dealt with in more detail in
chapter two. However, a brief explaination will now be given.
One of the core principles of the centrifugo-magnetophoretic principle
which is explored in this work is the separation of particles (cells or beads) of
varying size, density and magnetic susceptibility. The three main categories
are large non-magnetic particles (10− 20µm), large magnetic particles (10−
40µm) and small magnetic particles (1− 2µm), represented in fig 1.3.
Under application of the centrifugal force on a microparticle suspended
in a stationary fluid, particles will undergo sedimentation at a particular ve-
locity. This velocity is dependent on many factors, the speed of rotation, the
mass of the particle, the size and shape of the particle, the density difference
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Figure 1.3: Under application of the centrifugal force on a microparticle
suspended in a stationary fluid, those particles will undergo sedimentation.
The relative velocities of three types of particles is indicated above. Non-
magnetic polystyrene 20µm beads (blue) were the slowest, followed by the
1µm magnetic beads and finally the 20µm magnetic beads. The reason for
this velocity difference is outlined in chapter 2.3.1.2
between the particle and fluid, and the viscosity of the fluid, to name but
a few. These factors are all collected together to determine the three main
forces which govern the particle motion. These are the centrifugal force (Fω),
the drag force (Fd) and, for magnetic particles, the magnetic force (Fm). A
more in-depth analysis of these forces is given in chapter 2.3.1.
1.5.1 Superparamagnetic polymer beads
Superparamagnetic particles are single domain ferromagnetic nanoparticles
which have zero magnetisation in the absence of a magnetic field due to their
small size which allows their direction of magnetisation to flip randomly due
to normal temperature fluctuations [30]. This gives the particles an overall
average magnetisation of zero, unless an external magnetic field is present.
The magnetic micro-beads used in this work are all of the superparamag-
netic variety, that is, they are polystyrene micro-beads throughout which a
dispersion of superparamagnetic nanoparticles are to be found (Fig. 1.4).
The specific details of each type of particle used are given in the materials
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and methods sections of the upcoming chapters. However, being superpara-
magnetic, the basic structure of the beads are all the same. For simplicity,
superparamagnetic beads are simply referred to as “magnetic beads” in most
of this work.
Figure 1.4: Superparamagnetic beads consist of a polystyrene bead through-
out which a number of single domain superparamagnetic nanoparticles are
dispersed. This allows the superparamagnetic effect to be created for a par-
ticle much greater in size than the typical superparamagnetic nanoparticle
1.6 Pseudo cells
Throughout this work, polystyrene microbeads were used as “pseudo cells” in
order to prove the physical principle of cell separation and detection on the
various platforms here-discussed before actual blood and cancer cells were
then used. These polystyrene microparticles provide an excellent approxi-
mation of the behavious of cells in suspension on a centrifugal microfluidic
platform. The polystyrene microparticles used for this work have a density
of (1050Kg/m3) which is very close to that of an actual blood cell or can-
cer cell in blood 1080 ± 5Kg/m3 [31]. And a superparamagnetic microbead
of 10-20µm very closely approximates the behaviour of a cell that has been
tagged with numerous 1µm magnetic beads (Fig 1.5).
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Figure 1.5: a) Microscope image of a cluster of MCF7 breast cancer cells that
are coated with many 1µm magnetic beads, resulting in the dark black/brown
colour. b) A schematic of a superparamagnetic polystyrene microparticle of
the same size as the cell cluster. The black dots represent the magnetic
nanoparticles within the microparticle. c) The red dots represent the un-
bound 1µm beads that can be seem in the background of (a). They are
composed of the same nanoparticle interior as the larger particle in (b).
A calculation of the iron content of a 20µm magnetic bead (Microparticles,
GmbH) and an MCF7 cell coated with 200 1µm magnetic beads (Micropar-
ticles GmbH) was undertaken to determine how accurate this approximation
was. Based on the percentage of ferrous content (20% by volume) given by the
supplier, a 20µm magnetic bead was found to have a mass of 3.12x10−12Kg
of ferrous material in each bead. When compared to a MCF7 cell cluster in
fig 1.5 with approximately 200 1µm magnetic beads on its surface, the total
mass of ferrous material on the surface of the “tagged cell” was found to be
4.81x10−13Kg. It was felt that this was close enough to assume that a 20µm
magnetic bead would provide a reasonable approximation of the behaviour
of a magnetically tagged MCF7 cell.
The beads also had the advantage of having highly homogeneous proper-
ties and being very easy to visualise on the spinstand and microscope. This
enabled quick and accurate tests and calculations to be carried out before
moving on to the more complex biological samples of blood and cancer cells.
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Chapter 2
Centrifugo-Magnetophoretic
Particle Separation
This chapter is based on the following publication:
Centrifugo-magnetophoretic particle separation,
Daniel Kirby, Jonathan Siegrist, Gregor Kijanka, Laetitia Zavattoni, Orla
Sheils, John OLeary, Robert Burger and Jens Ducre´e,
Microfluidics and nanofluidics 13.6 (2012): 899-908.
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Before a fully functional CTC detection device with integrated sample-
prep, cell isolation and on-board detection could be envisaged, it was nec-
essary to first prove the physical principle of centrifugal-magnetophoresis.
Once this was done, the door would be opened for the manifold poten-
tial applications for stopped-flow magnetophoretic separations of cells, pro-
teins, and nucleic acids in bioanalytics, cell biology, and clinical diagnos-
tics. To ensure stable hydrodynamic conditions and thus reproducible sep-
aration, state-of-the-art magnetophoretic lab-on-a-chip systems have been
based on pressure-driven flow [2–4], which involves rather bulky and costly
instrumentation. In a flow-based system, suspended particles are following
the liquid phase as a result of the Stokes drag, thus being fully exposed
to divergent flow lines around obstacles and pump-induced pressure fluc-
tuations. In order to eventually achieve more stable hydrodynamic con-
ditions, improved control of magnetic particles, a more compact instru-
mentation footprint, and integration of high-performance upstream sample
preparation, this chapter introduces the novel 2 dimensional particle separa-
tion principle (centrifugal-magnetophoresis) by combining magnetic deflec-
tion with centrifugal sedimentation in a stopped-flow mode (i.e., mere parti-
cle sedimentation). The experimental parameters governing our centrifugo-
magnetophoretic system are the strength and orientation of the co-rotating
magnetic field, the rotationally-induced centrifugal field, and the size-dependent
Stokes drag of the various particles with respect to the (residual) liquid phase.
In this work, the following set of basic functional modes is demonstrated as
proof-of-concept: separation of magnetic from non-magnetic particles, rout-
ing of magnetic particles based on control of the spin speed, and size separa-
tion of various magnetic particles. Finally, a biomimetic application involving
the separation of particles representing healthy cells from a very small con-
centration of magnetic particles of a similar size, mass and magnetization as
a immuno-magnetically tagged target cell.
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2.1 Introduction
While large, automated systems, such as fluorescence and magnetically-
assisted cell sorters (FACS and MACS, respectively), have been successful
in analysis of cells, their associated instrumentation and operation proves
to be bulky, complex, and expensive [5]. Thus, the development of smaller-
scale, microfluidic cell capture and isolation systems remains of high inter-
est. Such systems would benefit from the commonly quoted advantages of
microfluidics (e.g., high amenability to automation, process integration, mul-
tiplexing and parallelization, substantially reduced sample and reagent vol-
umes, smaller instrument footprint, portability, low costs of ownership) while
possibly gaining additional functionality over current macrofluidic systems
[32, 33]. However, proof-of-concept of such a system will only transfer into
useful applications if it can be integrated with upstream sample preparation
[34] to form a full-fledged sample-to-answer technology. In the case of rare
cell detection from whole blood, the platform utilized must also be able to
process and handle the comparatively large blood-sample volumes in a low-
loss fashion to obtain statistically representative counts of these bioparticles
[9]. A common, general method for biological separation is the linking of
analytes with particles/beads, followed by the subsequent control and sep-
aration. This continues to be a feasible approach to the problem, and has
already found widespread commercial applications using magnetic particles
[2, 5]. Smaller-scale systems have also been developed, including microfluidic
continuous-flow and magnetophoretic systems [2, 3, 35, 36]. To date, prac-
tically all continuous, microfluidic separation systems have been flow-based,
pressure-driven systems. However, such implementations exhibit inherent
disadvantages. Initial particle focusing is an issue, as the microparticles
tend to follow divergent flow lines to compromise resolution [37]. Moreover,
pressure-driven systems, while providing good control at larger flow rates,
tend to be difficult to manage at low flow rates, which are required for mi-
croparticle control and focusing [18, 21, 38, 39]. In an effort to overcome these
disadvantages, this work adapts a magnetophoretic system onto a rotational
lab-on-a-disc platform operating in stopped-flow mode. The centrifugal, ar-
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tificial gravity force propels particles through a stagnant carrier fluid and
separates/routes them according to their density, size, and magnetic prop-
erties in the presence of a co-rotating, permanent magnet polarized in a di-
rection perpendicular to the centrifugal force. Apart from the elimination of
(divergent) flow lines, obvious advantages are gained with the centrifugal sys-
tem as compared to common pressure-driven schemes, including the simple,
cost-efficient, low-maintenance instrumental setup (CD player), the ease-of-
handling of the disc-shaped substrates (CDs or “discs”) that do not require
tubing interconnects, and the freely-programmable and inertially-stabilized,
jitter-free centrifugal actuation mechanism that features a large force range
and a rotationally-symmetric field for facile parallelisation [18, 21, 39, 40].
2.1.1 System concept, design, and advantages
In this chapter, we describe a magnetophoretic system inspired by the con-
cepts of Pamme and Manz [3] that was for the first time adapted onto a
centrifugal microfluidic platform towards cell separation applications. The
device works by centrifugally sedimenting particles in a stagnant carrier fluid
through a magnetic field generated by disc based permanent magnets (Fig.
2.1).
The novel, 2-dimensional, centrifugo-magnetophoretic system is governed
by the interplay of several experimental control parameters and forces as
follows: rotational spin-speed (controls centrifugal field), particle size and
viscosity of the carrier fluid (affects Stokes drag), particle density (impacts
sedimentation rate), and the geometry of the separation chamber (controls,
for instance, particle residence time and magnetic field distribution). More-
over, the strength, position, and orientation of the co-rotating permanent
magnet can also be customized. The entire system (Fig. 2.2) is first primed
with liquid. Next, a particle suspension is introduced to the loading chamber.
After mounting of the on-chip permanent magnet, the hybrid, microfluidic
disc is placed on a spin-stand motor and rotated at various speeds to centrifu-
gally sediment and separate/route the particles. The particles first enter the
focusing channel where they are aligned along the wall distant to the magnet
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Figure 2.1: a) Photograph of a single centrifugo-magnetophoretic separation
device on the disc with relevant features labeled. b) Schematic and magnetic
model showing the separation forces present in the system with calculated
trajectories and destinations of 3 different particles. The centrifugal force Fω
and the magnetic force Fm are also displayed, with magnetic field intensity
being represented by a colour gradient. Magnetic modeling was done with
the program FEMM-finite element method magnetics. c) Image of three-way
separation of beads at the opening of the separation chamber as outlined in
the schematic. 1µm particles have formed trains along the field lines and are
therefore visible as long streaks, not individual spheres.
(Fig. 2.1). Upon leaving the focusing channel, magnetic particles are imme-
diately deflected towards the permanent magnet near the opposite sidewall
of the separation chamber. Depending on the spin speed and their size, the
magnetic particles either arrive in the capture notch A or the collection reser-
voir C. In contrast, all non-magnetic particles sediment on straight, radial
trajectories through the separation chamber into reservoir B (Fig. 2.1).
It is worth emphasizing again that sedimentation occurs without flow;
particles merely sediment through the stationary carrier fluid, therefore elim-
inating impairment of the separation resolution caused by divergent flow lines
and hydrodynamic instabilities. Thus, if these magnetic and non-magnetic
particles are mixed and introduced simultaneously, they can easily be spa-
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Figure 2.2: Photograph of entire disc, showing six microfluidic chambers
with three magnets parallel to each chamber. The magnified views of the
individual chambers can be seen in Fig. 2.1.
tially separated, even under low hydrodynamic or mechanical stress (e.g.
compared to just holding a permanent magnet against the outer wall of the
vessel). Within the wide spectrum of possible system designs and operational
parameters, this proof-of-concept strategy reports on a specific geometrical
layout that was chosen to display several basic functional modes of the cen-
trifugal magnetophoretic system. In this work, silicone discs are fabricated
and tested to first show separation of magnetic from non-magnetic particles.
Next, separation of different sizes of magnetic particles is shown, followed
by routing of a fixed type of magnetic particle to a designated location con-
trolled by the rotational spin-speed. Finally, we present a 3-fold differential
separation of a mixture of non-magnetic particles and magnetic particles of
different sizes. This particle separation may be regarded as biomimetic of an
actual sample of untagged cells, magnetically tagged cells and excess tagging
particles.
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2.2 Materials and Methods
2.2.1 Device fabrication
The microfluidic devices were designed in AutoCAD (Autodesk, Inc., CA,
USA) and fabricated out of polydimethylsiloxane (PDMS) (Sylgard 184, Dow
Corning; #101697, Farnell, UK) using standard SU-8 soft-lithography pro-
cesses [41, 42]. A two-level, SU-8 mold was created on a bare, 4 inch Si
wafer by first spinning on SU-8 3050 (Microchem, MA, USA) to a thickness
of 100µm; this first layer formed the focusing channels and separation cham-
bers (Fig. 2.2). The second SU-8 layer was spun on to a thickness of 150µm
and formed the loading chambers. Baking, UV exposure, and developing
steps were performed separately for each layer according to the manufactur-
ers recommendations. Note that each disk contains 6 identical separation
structures. After creation of the SU-8 mold, it was cleaned using UV/ozone
for 5 minutes and then silanized using octadecyltrichlorosilane (#O5877,
Sigma-Aldrich, IE) vapors for at least 4 hours to promote PDMS release. To
prepare the PDMS, Sylgard 184 curing agent and base were mixed in a ratio
of 1:5 by weight, degased, poured over the SU-8 mold, degased again until all
bubbles were eliminated, and then cured in an oven at 70°C for 1 hour. The
PDMS part was removed from the mold, and holes, including the center hole,
loading holes, and permanent magnet holes, were punched and cut out from
the disc manually. Next, stock 2-mm thick polymethylmethacrylate (PMMA)
(#824-632, Radionics, IE) was laser cut into a standard CD format (10-cm
diameter) and cleaned using isopropanol and DI water. Sylgard 184 curing
agent and base, mixed this time in a mass ratio of 1:20, was mixed, degased,
and spun onto the PMMA disc at 1500 revolutions-per-minute (RPM). The
PDMS-coated disc was then cured in an oven at70°C for 1 hour. Finally,
the PDMS microfluidic device, with pre-cut holes, was manually aligned to
the PDMS-coated PMMA base. The PDMS-to-PDMS bond was enabled by
the mismatch in the concentrations of the curing agent [43], thus forming a
practically irreversible bond between the PDMS layers. Adhesion between
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the spun-on PDMS and clean PMMA disc was completely leak-proof at the
spin-speeds used in these experiments.
2.2.2 Spin-stand instrument
To run the separation experiments, a servo-motor coupled to a stroboscopic
visualization system similar to that already described in Chapter 1.3 was
used for particle flow and tracking during rotation. A servo-motor (4490
series, Faulhaber, DE) was mounted to a framed support, and a custom
chuck was machined for securely attaching standard discs to the servo-motor
shaft. A CCD camera (Sensicam series, PCO, DE) was placed directly above
the motor, and a combination of optical components (Navitar, NY, USA)
and controls for particle visualization were attached to the camera to obtain
a microscopic image; the optical setup also included a motorized zoom and
focus to allow for multi-scale imaging of features on the microfluidic device.
A linear drive was used to radially position the camera along the disc. The
camera was triggered to capture one frame per rotation, such that a movie
composed of a sequence of still images taken at the same location on the disc
could be acquired. A custom control box was fabricated to handle triggering
between the motor, camera, and stroboscopic illumination system; the trigger
box also served to control the circumferential location along the disc for
image acquisition. The combined action of the linear camera drive and the
trigger box provided full control to select the desired sector of the disc to be
investigated and imaged. The stroboscopic system (Drelloscop 3244, Drello,
DE) utilized a liquid light-conductor for illumination and was mounted above
the disc and to the side of the camera. A desktop PC (Dell, US) was used to
control the spin-speed and sequences of the motor as well as for monitoring
and image acquisition. The custom spin-stand instrument allowed for real-
time movement and magnification such that the flow of particles through
the microfluidic device could be tracked. The optical clarity of the PDMS
and PMMA device components, the bright stroboscopic illumination as well
as coloring of the particles (see figure 2.3) provided adequate contrast for
visualization.
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2.2.3 Particle separation experimental materials
Various types of particles were sourced for characterizing the centrifugal-
based magnetophoretic system. The particles used included polystyrene par-
ticles (d = 20µm; ρ≈1.1gcm−3; #PS, MicroParticles, GmbH, DE), and iron-
core, paramagnetic polystyrene particles of two different sizes (d = 1.43µm
and 18.8µm; ρ≈1.7gcm−3; #PS-MAG-S1792, #PS-MAG-S1985, and #PS-
MAG-S1986, MicroParticles, GmbH, DE). The polystyrene particles were
yellow and the magnetic particles were red; this allowed for easy visualiza-
tion and differentiation on the spin-stand instrument and under the bright-
light microscope. Particle sizes will be referred to as 20µm (magnetic and
non-magnetic), and 1µm (magnetic) for convenience. All particles arrived as
either 5% or 10% w/v solutions. After vortexing and/or sonication to ho-
mogenize the suspensions, dilutions of each particle type were made through
a 1:10 ratio of particles to medium. The dilution medium consisted of PBS
(phosphate buffered saline, 0.1 M phosphate buffer, 0.0027 M potassium chlo-
ride and 0.137 M sodium chloride, pH 7.4) with 0.1% BSA (bovine serum
albumin). All particle mixtures were vortexed briefly before introduction to
the disc.
2.2.4 Biomimetic separation experimental materials
For the biomimetic cell separation experiments (as already described in chap-
ter 1.6), red, 20µm magnetic particles were used to mimic cells of a similar
size, mass and iron content which are coated with several hundred biofunc-
tionalized 1µm magnetic beads. Background, i.e. untagged blood cells were
represented by 20µm polystyrene particles as they were of a similar mass
as blood cells and exhibit a different colour to the magnetic particles. Fi-
nally, a real-world analytical sample would exhibit excess tagging particles,
in this case 1.43µm, magnetic iron cored polystyrene particles. These were
also included in the sample to give a more realistic biomimetic blood sam-
ple of 20µm polystyrene beads, 20µm iron cored polystyrene beads and 1µm
iron cored magnetic beads. This sample was then processed through the
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centrifugo-magnetophoretic system and 3-way separation was observed as
will be discussed in section 2.3.
2.2.5 Experimental protocol and data analysis
After assembly and fabrication (see section 2.1), the microfluidic disc (Fig.
2.2) was primed with an excess (50µL) of solution using degas-driven flow [44]
and then placed onto the spin-stand instrument. Nickel-plated, rod-shaped
permanent magnets made of NdFeB (3 mm diameter, 6 mm long) (S-04-10-
AN, SuperMagnete, DE) were mounted on the disc. Next, 3µL aliquots of
the various microparticle mixtures were placed in the loading chamber and
then centrifugally sedimented through the system; spin speeds in the range
of 225 RPM to 750 RPM were evaluated. A spin speed of 420 RPM (7Hz)
was found to feature optimum separation of particles. The trajectories of
the deflected particles were monitored using the stroboscopic imaging sys-
tem described above and total number of particles trapped in each area was
calculated using the theory of random loose packing [45] where the captured
number of particles was large, and counted under an optical microscope where
the number was small (roughly less than 20) and easily visible. Particle de-
flection/separation was quantified by calculating the percentage of particles
that ended up in each of the three chambers with the 1µm magnetic beads
to go in to chamber A the 20µm non-magnetic beads to go into chamber B
and the 20µm magnetic beads to go into chamber C (Fig. 2.3).
2.2.6 Magnetic modeling and measurements
To initially optimize the position and properties of the on-disc permanent
magnet, we simulated the magnetic fields for various types and positions of
permanent magnets (Fig. 2.1b) with the software package FEMM (Finite
Element Method Magnetics 2010). It was found that magnets producing a
high magnetic field gradient would be needed for this system, and so NdFeB
magnets were chosen. It was also determined that 3 rod-shaped magnets
(3mm diameter, 6mm long) placed at a distance of approx. 2.5mm from the
side and staggered along the length of the separation chamber would exhibit
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a suitable magnetic flux density and field strength of 130mT . Furthermore,
the magnetic field gradient (as a gross linear approximation) amounted to
roughly 50mTmm−1. The positioning of the magnets was selected by edu-
cated guess initially and then further optimized empirically. To validate the
simulation results, the magnetic field was also measured using a Gaussmeter
(#CYHT201, Chen Yang Technologies, DE). We measured a magnetic field
strength of 100mT and a magnetic field gradient (again as a gross linear
approximation) of 30 mTmm−1, correlating well with the modeled data.
Figure 2.3: Images of captured particles from three separate experiments
where 100% of the beads went to their intended capture areas. Capture area
A: 1µm magnetic beads were deflected strongly due to their slow sedimen-
tation speed and 100% trapping was observed. Capture area B: 100% of the
20µm non-magnetic beads were recovered. Capture area C: Again, 100% of
the 20µm magnetic particles were retrieved.
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2.3 Results and discussion
The work described in this chapter focuses on the general introduction of
the fundamental concept of centrifugo-magnetophoretic separation. A pre-
liminarily optimized, fixed magneto-microfluidic system configuration was
chosen from a wide range of possible layouts to demonstrate various basic
functional modes of the system. Experimental results from the solely particle-
based experiments are first presented (Fig. 2.4), showcasing magnetophoretic
separation capabilities of our novel system along with considerations of the
relative forces involved. Finally, the results of biomimetic experiments are
highlighted, showing the high potential for real-world applications (Fig. 2.5).
2.3.1 Particle-based results and discussion
We start this section with a brief description of the forces present in this sys-
tem to leverage the interpretation of the subsequently presented experimental
results and functional modes.
2.3.1.1 Separation forces
Particle motion in the system is governed primarily by the centrifugal (Fω),
magnetic (FM) and velocity-dependent Stokes drag (FD) forces. At elevated
particle speeds (relative to the disc), the rotational Coriolis force (FC) also
plays a role in the particle routing mechanism. Briefly, the Coriolis force,
which acts in the same plane as the disc, forces particles in a direction per-
pendicular to that of the centrifugal force and opposite to that of the direc-
tion of rotation. In fact, for a sufficient magnitude at high sedimentation
speeds, the Coriolis force may artificially enhance or counteract the observed
magnetic deflection/routing. The relative strengths of the forces acting on
a single magnetic particle can be estimated based on known and observed
characteristics of the platform in combination with the results obtained from
the magnetic modeling and measurements. The following equations describe
the magnitudes of the four forces present in the system:
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where ∆ρ is the density difference between the particle and the liquid,
d its distance from the particle center to the center of the disc, ω is the
angular frequency of the disc rotation, ∆χ is the difference between χP and
χM , the magnetic (volume) susceptibilities of the particle and the medium,
respectively, VP is the volume of the particle, B is the magnetic flux density
that arises from the on-chip permanent magnet, µ0 is the vacuum perme-
ability constant (1.2566x10−6V sA−1m−1), η is the viscosity of the carrier
fluid, r0 is the radius of the particle, and ν is the velocity of the parti-
cle [3, 18]. Equation 2.3 is the expanded form of equation 2.2. For the
purposes of these calculations, a 20µm magnetic particle with a density of
1.9gcm−3 is located at the side of the separation chamber closest to and ra-
dially aligned with the magnet (at a distance from the center of rotation of
about 35 mm). It is worth noting that a particle at this position experiences
a maximum magnetic force, and a measured magnetic flux density on the
order of 100mT with an approximate linear gradient of around 30mTmm−1
which was used for the calculations. The magnetic (volume) susceptibility
of the particle is assumed to be on the order of 0.15 (dimensionless) based
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on previous publications, and water is the carrier fluid [3]. At a spin speed
of 420RPM a mean particle sedimentation velocity of 137± 12.6µms−1 was
experimentally observed using Tracker video analysis and modeling software
(http://www.cabrillo.edu/ dbrown/tracker/) over 4 experiments. Based on
these assumptions, an estimation of the strength of the forces acting on a
single magnetic particle in the x direction (towards the magnet) is obtained
as follows:fM = 1, 500pN , fω = 480pN , fD = 26pN , and fC = 0.09pN .
Thus, the predominant forces are the magnetic and the centrifugal forces,
while the Stokes drag and Coriolis forces are less prevalent. To better under-
stand the increased ratio between the two dominant forces (fM/fω = 3.1) in
view of the rather moderate deflection angles observed, one must consider the
transient nature of the magnetic force as experienced by the particle. While
the centrifugal force is unidirectional and high in magnitude along the entire
radial length of the separation chamber (about 20 mm), the particle experi-
ences strong, lateral magnetic-force components only when in close proximity
to the magnet; this strong magnetic force is thus experienced throughout a
radial travel distance roughly corresponding to the width of the permanent
magnets (3 mm). These crude approximations provide a 3.1-fold higher mag-
nitude and a 6.7-fold reduced interaction interval of the magnetic force with
respect to the centrifugal force. Thus, it can be concluded that in the time-
average over the two forces, their effective impact on the particle trajectory is
comparable and can therefore be utilized to fine-tune the routing of magnetic
particles through the separation chamber.
2.3.1.2 Particles’ terminal velocity
The calculations for particle velocity in the previous section were carried out
using an experimentally observed velocity to determine the drag force due to
the particle velocity at that point in time. There are inherent complications
in calculations such as these due to the velocity change of the particle with
respect to time. It was therefore thought important to carry out calcula-
tions to determine the terminal velocity of particles of two different sizes in
order to explain the velocity difference between the slow 1µm beads and the
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much faster 20µm beads. This can easily be explained by the analogy of the
terminal velocity of an object falling to earth under the gravitational force.
At terminal velocity, the acceleration of the object will go to zero and the
viscous drag force from the air will be equal to the gravitational force on the
object. This analogy is precisely the same for the microparticles sedimenting
through the stagnant fluid. At terminal velocity the viscous drag force on the
microparticle fD will equal the centrifugal force fω on the microparticle and
this allows for a calculation of the terminal velocity to be undertaken. The
terminal velocity of a 1µm magnetic bead at a distance of 35mm from the
disc centre was found to be 0.22µm/s and the terminal velocity for a a 20µm
magnetic bead at the same location was found to be 39µm/s. This clearly
explains the observed velocity difference between the particles, even though
the 1µm particles were slightly more dense due to a higher iron content.
2.3.1.3 Separation of magnetic from non-magnetic particles
The fundamental capability of centrifugo-magnetic separation is first demon-
strated in its most simple variant, the capture of 20µm non-magnetic beads,
20µm magnetic beads and 1µm magnetic beads in three separate capture ar-
eas at a spin rate of 420 RPM (Fig. 2.3). As already discussed, the selective
routing of the beads to designated capture zones roots in the specific inter-
play of the centrifugal force fω, magnetic force fM and the Stokes drag fD.
The non-magnetic particles simply follow fω to sediment straight down the
channel. The 20µm magnetic beads are additionally impacted by fM to lat-
erally deflect them into capture area C. And finally, the 1µm magnetic beads
(despite having a slightly higher density than the 20µm magnetic beads) sedi-
ment at a considerably lower velocity due to the ratio of centrifugal to viscous
forces being proportional to r2 [29] and thus experience a greater deflection
by the lateral magnetic field fM into the capture area “A” due to their in-
creased time in the magnetic field and slightly higher iron content(Fig. 2.3).
The next stage was the separation of magnetic from non-magnetic particles.
To this end a mixture of magnetic and non-magnetic polystyrene particles
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of similar size (≈ 20µm in diameter) were processed at a spin speed of 420
RPM for about 20 min.
Figure 2.4: After introduction of a mixture of yellow, 20µm non-magnetic
beads and red, 20µm magnetic beads into the loading chamber, the system
was spun at 420 RPM. A complete, 100% separation of the beads was ob-
served.
The results in Fig. 2.4 feature an excellent degree of accuracy and exhibit
100% separation of 20µm non-magnetic from 20µm magnetic beads. The
next mixture of particles separated was 20µm non-magnetic beads and 1µm
magnetic beads. Both types of beads followed the same pathway as they
did when run separately through the system (Fig. 2.3) with 100% of non-
magnetic 20µm beads captured ending up in capture area B and 100% of 1µm
magnetic beads captured ending up in capture area A. The initial branching
of the bead trajectories upon entering the separation chamber in (Fig. 2.1c)
shows the 1µm beads forming trains of beads as they line up along the
magnetic field lines [46] and deflecting to the right-hand magnets, with the
20µm non-magnetic beads continuing radially outwards.
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It should be mentioned that the Coriolis force fC may to a small extent
artificially enhance the observed magnetic separation. However, we selected
the of rotation such that fC counteracts fM , thus preventing an enhancement
of the lateral deflection. So the experimental results obtained on the here
presented choice of the centrifugo-magnetophoretic system design with the
specified control parameters provide clear evidence for capability of particle
focusing and separation.
2.3.2 Biomimetic separation results and discussion
The final set of experiments was performed to mimic the realistic conditions
of extremely rare CTCs suspended in the blood stream. Typically, one CTC
would be present in a background of roughly a million white blood cells and
a billion red blood cells. Our biomimetic sample consisted of a very high con-
centration of 20µm polystyrene beads (“pseudo blood cells”) spiked with a
minute concentration of 20µm magnetic beads (“psuedo magnetically tagged
rare cells”) and a high concentration of 1µm beads (excess, i.e. unbound mag-
netic tagging beads). Note that at this pioneering stage of our research the
CTC-to-blood-cell ratio chosen is still significantly higher in our biomimetic
sample than in a patient blood to avoid problems with the otherwise required
handling of large-scale, milliliter volumes on miniaturized lab-on-a-chip sys-
tem. The final test consisted of 5 runs with an average content per run of
≈ 16, 300 non-magnetic beads (20µm, i.e. mimicking non-target cells), ≈ 37
magnetic beads (20µm, i.e. mimicking tagged target cells) and ≈ 700, 000
magnetic tagging beads (1µm, i.e. mimicking unbound magnetic tags).
These samples were separated with extremely high selectivity (Fig. 2.5
& table 2.1). It was observed over the 5 runs that 96.3 ± 11.2% of the
20µm magnetic particles (representing CTCs) were captured in the correct
terminus C, there were only a small fraction (3.7%) of false negatives (CTCs
in B) and less than 0.1% false positives (regular blood cells in C).
While this level of error is very small, it would be an unacceptable amount
of error if the system were scaled up to handle realistic CTC concentrations.
The reason for the error was observed to be non-specific binding of a non-
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Capture area 20µm non-magnetic 20µm magnetic 1µm magnetic
A 3(0.02%) 0(0%) 7.1× 105(100%)
B 16, 344(99.93%) 1.4(3.7%) 0(0%)
C 9(0.05%) 36(96.3%) 0(0%)
Table 2.1: Statistical data from n=5 runs of 3-way particle separation
magnetic bead (regular blood cell) to a magnetic tagging bead and its result-
ing routing into chamber C. This issue may possibly be resolved by suitable
optimization of bioanalytical immuno-binding and blocking strategies.
2.4 Conclusion and outlook
In this work, a novel centrifugo-magnetophoretic platform for particle separa-
tion was conceptually introduced and experimentally investigated. According
to their physical properties, such as size and magnetization, the distribution
of the magnetic field, and the freely-programmable spin speed, the platform
is capable of routing microparticles into one out of three available outlets.
For a chosen system configuration, a set of basic functional modes was in-
vestigated using a range of particle types and rotational frequencies. In this
proof-of-concept study, prospective cell separation capability was evaluated
by biomimetic experiments utilizing particles of similar mass, size and mag-
netization as target and background cells as well as an abundance of 1µm
magnetic tagging particles. The main advantages of the simple and robust
platform are the very stable hydrodynamic conditions in the centrifugally
enabled, jitter-free, stopped-flow mode which is unique to the centrifugal
platform. The results of these tests enabled the work to move on to more
advanced biological cell separation, as show in figure 2.6 and described in the
upcoming chapters.
As established in the literature, the centrifugal microfluidic platform is
also well-amenable for powerful sample preparation, including classic meth-
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Figure 2.5: Results of biomimetic experiments with a large concentration of
20µm yellow non-magnetic beads and red 1µm magnetic beads representing
healthy cells and tagging particles respectively and a very low concentration
of red 20µm magnetic beads representing tagged cancer cells. The position of
the images (taken from one of the 5 runs) is indicated on the schematic. The
separation was done with a very high affinity, very close to 100%. Statistical
results from the five runs can be seen in table 2.1 which indicates the average
number of each particle captured in each area. Percentage values are also
given. The fact that this level of separation can be achieved from a mixed
population of three samples shows great promise for applying this system to
separate cells in a blood sample.
ods such as blood separation through centrifugation [18, 21, 39, 41, 47, 48].
This suggests great opportunity towards a full-fledged, high-performance
sample-to-answer system for a wide spectrum of applications involving a cell
separation function.
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Figure 2.6: Schematic of the centrifugo-magnetic principle as applied to sep-
arating magnetically tagged cancer cells from a background of healthy blood
cells and excess tagging beads. The principle is the same as the bead sepa-
ration and shows great promise as a method of separating cells, for example
CTCs from a background of healthy cells.
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Chapter 3
Cell based on-disc
magnetophoresis and
enumeration
This chapter is based on the following publication:
Rapid and Cost-Efficient Enumeration of Rare Cancer Cells from
Whole Blood by Low-Loss Centrifugo-Magnetophoretic Purifica-
tion under Stopped-Flow Conditions,
Daniel Kirby, Macdara Glynn, Gregor Kijanka, Jens Ducre´e,
Cytometry Part A 87.1 (2015): 74-80.
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Following on from the results in chapter 2 where biomimetic “pseudo
cells” were used to prove the principle of centrifugal magnetophoresis, the
substantially improved design and functionality of the centrifugo-magnetophoretic
platform which integrates direct immuno-separation and cost-efficient, bright-
field detection of cancer cells in whole blood was developed. Like the earlier
device, we aimed to contain all microfluidic and magnetic components on
the convienient footprint of a common CD and the same centrifugal spin-
stand instrument was used for rotation and visualisation of the disc. In a
first step, target cells in a blood sample are specifically bound to param-
agnetic microbeads. The sample is then placed into the disc cartridge and
spun. In the second step, magnetically tagged target cells are separated by
a co-rotating, essentially lateral magnetic field from the background popu-
lation of abundant blood cells, and also from unbound magnetic beads. A
stream of target cells centrifugally sediments through a stagnant liquid phase
into a designated detection chamber. The continuous, multi-force immuno-
separation proceeds very gently, i.e. the mechanical and hydrodynamic stress
to the target cells is minimized to mitigate the risk of cell loss by collective
entrapment in the background cells or vigorous snapping against a wall. We
successfully demonstrate the extraction of MCF7 cancer cells at concentra-
tions as low as 1 target cell per µl from a background of whole blood, with
capture efficiencies of up to 88%. Its short time-to-answer is a notable char-
acteristic of this system, with 10% of target cells collected in the first minute
after their loading to the system, and the remainder captured within the
following ten minutes. All of the above mentioned factors synergistically
combine to leverage the development of a prospective low-cost point-of-care
device for CTC detection.
3.1 Introduction
Over the past two decades interest in the centrifugal microfluidic lab-on-a-
disc (LoaD) concept[18] has significantly increased, in particular for bioana-
lytical assays. The platform has been applied to successfully integrate liquid
handling and detection for endpoints such as sample nucleic acid amplifica-
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tion, immunoassays [49] and cell analysis [19, 40] The use of the inherent
centrifugal field to transport and manipulate (liquid) analytes and reagents
(rather than through complex actuation schemes such as pumps) makes the
LoaD platforms particularly attractive for point-of-care (PoC) settings where
both, cost-efficiency and robustness are prerequisites. Processing of the dis-
posable disc-cartridge generally requires a speed-adjustable spindle motor
as, for instance, found in conventional DVD players; indeed, such cartridges
have previously been processed by the DVD-ROM drive of a laptop [50].
Additionally, the innate ability of centrifugal sedimentation makes LoaD
platforms particularly suited to blood processing and cell handling. Very
dynamically emerging trends of personalised medicine and acute healthcare
have underpinned the need for advanced point-of-care (PoC) devices or com-
panion diagnostics which can be deployed at the bedside in hospitals, in
doctors offices and even at home for patient self-testing. Classically these
tests have been carried out in central laboratories, involving long time-to-
answer and high costs of instrumentation. Microfluidic platforms bear the
promise to enhance patient comfort through fewer visits to clinics and more
gentle blood sampling due to reduced volume requirements while alleviat-
ing the burden on health-care budgets. In addition to mobile monitoring of
disease, these devices have also become a major driver of cell-based medical
analysis in clinics and hospitals. A primary objective for such application
is in the detection of extremely rare circulating tumour cells in whole blood
samples. The field has considerably advanced in recent years, [51, 52] with a
growing number of research groups investigating a range of aspects, from bio-
logical characteristics of cancer cells [53] such as the links between CTCs and
metastases [54], to instrumentation designed for diagnostics based on count-
ing the actual CTC numbers present in the blood [6], associated prognosis
[55], methods of enumerating and detecting CTCs [51, 56, 57] and research
into developing diagnostic devices which are able to detect CTCs in typical
clinical settings [52]. Tools for CTC detection are expected to provide im-
portant, ideally patient-specific information for cancer prognosis, diagnosis,
assessment of minimal residual disease and assessment of anti-cancer drugs
[58]. Much effort is directed towards the development of microfluidic sys-
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tems for detecting CTCs [59–63]. The paramount challenge is the extreme
sparseness of such cells. While the CTC concentration in a patient sample
is known to vary greatly with cancer type and stage [56], the scientific com-
munity has not yet been able to define a gold standard experiment for the
unambiguous identification of a CTC; hence also a wide consensus on their
concentration range is notably lacking. Nevertheless, we here follow the as-
sumption of a concentration in the range of 1 cell per µl [6, 7]. However, note
that some work refers to concentrations lower than 1 cell per ml [8], a con-
centration which would require an initial enrichment on our current system,
for instance implementing RBC lysis or buffy coat extraction. Due to the
extreme paucity of these cells, an efficient and reliable diagnostic instrument
must meet particular performance criteria:
1. A capture platform must isolate the entire CTC population present
(low loss, high capture efficiency).
2. It must discard background non-target cells (high isolation purity/specificity).
3. It must perform this analysis sufficiently fast.
4. It must handle rather large volumes of sample (high system through-
put) [52].
CTCs have been distinguished based on size, deformability and density
[64–66]. However, these physical parameters may significantly vary through-
out the CTC population and thus also lead to significant overlap with normal
cells. The majority of platforms, including the first commercially available
CTC diagnostic system (Cellsearch, Veridex), therefore identifies CTCs based
primarily on their specific protein marker expression such as epithelial cell
adhesion molecule (EpCAM) via immuno-affinity binding [56] or immuno-
magnetic isolation [67–72]. In addition, negative markers, biophysical char-
acteristics (e.g. size and deformability) and morphological analysis of CTC
candidates are commonly employed. This chapter presents work on a novel
centrifugal microfluidic system that can magnetically isolate, enumerate and
detect rare cells on a low-complexity platform which is highly amenable to
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PoC diagnostics. The previous chapter demonstrated continuous separation
of magnetic beads of varying sizes from a large background of cell-mimicking
beads but this chapter will describe the advancement of the earlier technol-
ogy to isolate much lower, biologically relevant concentrations of cultured
MCF7 breast cancer cells (from cell lines) spiked into a whole blood sample.
We use paramagnetic, antibody-coated microbeads which target the MCF7
cells by binding to the EpCAM epitope expressed on these cells with very
high specificity. Our continuous-mode, centrifugo-magnetophoretic system
can therefore separate the input sample into its three superordinate con-
stituents: (red and white) blood cells, magnetically tagged target (cancer)
cells and excess unbound magnetic beads. A unique feature of this multi-
force separation is the removal of unbound paramagnetic beads from tagged
magnetic cells based upon the synergistic interplay of magnetic and cen-
trifugal fields with the size-dependent Stokes drag. While many platforms
[73] have used magnetic separation, they lack the ability to reliably sep-
arate unbound magnetic beads from isolated tagged target cells. This is
because such a purification, e.g. through integrated size filtration, tends to
be prone to clogging and unspecific trapping, and may thus lead to the loss
of scarce target cells which would be prohibitive for rare cell detection. Our
filter-less, flow-less sedimentation-driven system presented here, by design,
eliminates this critical flaw. Through the continuous sedimentation scheme,
we also mitigate the risk of cell damage due to vigorous snapping of beads
against the vessel wall and the risk of collective pull of entrapped target
cells by the abundant background population into the waste; these parasitic
loss mechanisms are deemed prevalent in common batch-mode magnetostatic
separations. Alongside presenting, for the first time, isolation of EpCAM
positive cancer cells in biologically relevant concentrations using continuous
centrifugo-magnetophoresis, we also demonstrate a proof-of-concept of a sim-
ple, bight-field method to quantitate the number of isolated cells based on
their packing volume in the capture chamber. This technique is similar to
established packed-cell-volume (PCV) haematocrit measure-ment [74] and is
also being used on other diagnostics platforms [75].
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3.1.1 Working Principle
In our stopped-flow, continuous sedimentation centrifugo-magnetophoresic
device (Fig. 3.1), the three forces governing the path of the particles through
the system, as discussed in detail in chapter 2, are the centrifugal force Fω,
the essentially lateral magnetic force Fm and the hydrodynamic Stokes drag
FD . Non-magnetic background blood cells will only experience the radial
centrifugal force Fω and the counteracting Stokes drag FD to sediment on a
straight path towards the peripheral edge of the disc. Concurrently, magnetic
particles will additionally experience the lateral magnetic field Fm, and thus
deflect from the main stream. The separation between unbound magnetic
beads and the magnetically tagged cancer cells (Fig. 3.1c) is primarily gov-
erned by the differences of (the densities of) their magnetic momenta; the
bulk magnetized beads possess a notably larger mean magnetic momentum
than the much larger cell / bead hybrids which only exhibit a magnetization
on the surface of their biological core. The resulting differential in lateral
magnetic deflection is enhanced by the steep increase of field gradient to-
wards the co-rotating magnet, which thus amplifies the spatial separation
compared to a (hypothetical) uniform field and deflection of cells, akin to
the “pseudo cell” deflection in chapter 2 is seen.
The two other factors, the centrifugal field and the viscous Stokes drag,
are significantly smaller in magnitude and do not directly alter the deflection
of the particle, i.e. the principal discriminator of our spatial separation tech-
nique. Instead, the interplay of these two counteracting forces mainly impacts
the (radial) speed of sedimentation, which is only indirectly resolved by our
technique through the residence time of the particles within the impact zone
of magnetic deflection. However, the density differences between our types
of bioparticles are significantly less pronounced than the differences in their
magnetization, so the centrifugal field only constitutes a secondary effect
in our separation mechanism. Our stopped-flow centrifugo-magnetophoresis
therefore drives a central stream of copious background cells into the radially
aligned, main waste chamber (labelled X in Fig. 3.1c). The most strongly
magnetized, free beads are directed into a laterally aligned gutter chamber
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Figure 3.1: Schematic of the polymeric lab-on-a-disc with microfluidic chan-
nels, visible in green, and magnets as silver cylinders. b) Bright-field micro-
scope image of two clusters of MCF7 cells tagged with paramagnetic beads
(background beads are visible as dark specks). c) Magnetic field simulation
of one of the green chambers from (a), with trajectories for blood cells, mag-
netically tagged (cancer) cells and excess magnetic beads. The directions of
the centrifugal (F) and magnetic (Fm) fields are also indicated. Blood cells,
excess beads and cancer cells are routed to the blood waste (X), bead waste
(Y) and target cell capture chamber (Z), respectively. Direction of rotation
is CCW.
(labelled Y in Fig. 3.1c) due to the balance of drag, magnetic and centrifugal
forces discussed in chapter 2.3.1. Finally, the less magnetised hybrids of the
target cells with the bead-tags are routed closer to the main sedimentation
direction into a slightly displaced, small detection chamber (labelled Z in
Fig. 3.1c). Direction of rotation is counter-clockwise (CCW), which means
any corialis effects will keep particles against the left-hand wall (Fig. 3.1c).
Due to the low speed of sedimentation of the particles in stopped-flow mode,
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the impact of the Coriolis force was found to be negligible, but the sense of
spinning direction was chosen as a precaution anyway. In this way our de-
sign provides a low-stress, three-fold spatial separation of background blood
cells, magnetically tagged cancer cells and excess tagging beads. Compared
to standard, batch-mode immunomagnetic separation with a simple mag-
net, our continuous, sedimentation-driven system separates the latter two
magnetic particles without the error-prone size filtration. Furthermore, the
novel, stopped-flow mode inherently eliminates flow-field instabilities which
tend to compromise resolution. Also, magnetostatic, batch-mode immuno-
separation often leads to collective entrapment of rare target cells in a cohort
of background cells. This loss mechanism is suppressed through the radi-
ally stretched distribution of the population of suspended cells through the
continuous sedimentation mode.
3.2 Materials and Methods
3.2.1 Disc Manufacture
The manufacture of the microfluidic discs was almost identical to the process
in chapter 2. But, in brief, the discs were formed from polydimethylsiloxane
(PDMS) (Sylgard 184, Dow Corning; #101697, Farnell, UK) by standard
soft lithography methods from a design drawn with AutoCAD (Autodesk,
Inc., CA, USA). A 100-µm thick dry-film photoresist (DuPont, NC, USA)
was hot-roll laminated onto a 4 inch silicon wafer, lithographically structured
by UV exposure and developed according to the manu-facturers instructions.
The dry film structures left on the wafer define the PDMS casted channels.
The millimetre-scale indentations for magnet positioning (Fig. 3.1 a) were
engineered with a 3D-printed polymer mould (uPrint, Stratasys Ltd., MN,
USA) and aligned via guide pins to create highly reproducible discs with
both, micro- and macro-features. After the PDMS had been poured into the
mould and hardened in the oven (1 hr at 70°C), the discs were assembled and
then placed for one hour into a vacuum chamber to allow subsequent, degas-
driven priming [44] with buffer (Phosphate buffered saline [PBS] with 10%
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EDTA and 1% casein). The magnets (S-03-06-N, Supermagnete, Germany)
were then placed into the pre-moulded voids on the PDMS disc.
3.2.2 The centrifugal spin-stand
The microfluidic disc is then loaded with sample and placed onto the same
custom designed centrifugal spin-stand as chapter 2, featuring a servo motor
(4490 series, Faulhaber, DE), a CCD camera (Sensicam series, PCO, DE)
connected to an optical imaging system (Navitar, NY, USA) and a strobe
light all synchronised via a PC (DELL, USA). The system records one image
per rotation, giving the user a live feed of the cells and microparticles as
they sedimented through the microfluidic chambers. This provided detailed
trajectory information and real-time counting of target cells, even during
high-speed rotation.
3.2.3 Bead and cell binding
The basic separation mechanism here presented is dependent on specific bind-
ing of the 4.5µm diameter magnetic microbeads to the target cells of interest
(Fig. 3.1 b) (Dynabeads Epithelial Enrich, Invitrogen Inc.). The Dynabeads
were diluted 80-fold from stock and incubated at a 1:1 volume ratio with
MCF7 cells spiked. All culture reagents were obtained from Sigma-Aldrich
(MO, USA) unless otherwise stated. MCF7 cells (DSMZ, Braunschweig, Ger-
many) were cultured in 75cm3 flasks in DMEM media, supplemented with
10% uninactivated foetal bovine serum (FBS), 100 U/ml penicillin and 100µg
/ ml streptomycin. Cultures were maintained at 37◦C with 5% CO2. Cells
were harvested by incubation in 5ml 0.25% trypsin / 0.1% EDTA at 37◦C
for 5 minutes followed by neutralization with 5ml culture medium. Cells
were centrifuged at 300g for 4 minutes and resuspended in culture medium.
Where indicated, live cells were fluorescently labelled with NucBlue Live Cell
Stain (Life Technologies, CA, USA) according to manufactures instructions.
Whole blood, MCF7 cells and Dynabeads were incubated in a capped 2ml
tube on a rotator for approx. 10 minutes at room temperature. It was noted
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that substantial MCF7-cell-to-bead binding was observed within less than 5
minutes.
3.3 Experimental Results
3.3.1 Centrifugo-magnetophoresis
Following incubation of the sample with magnetic beads, a 3µl aliquot was
loaded into each of the six chambers of the prepared microfluidic disc, pro-
viding a total volume of 18µl. This sample of whole blood, tagged MCF7
cells and excess beads was then sedimented through the system by rotating
the disc at a rate of 17Hz (55g at edge of disc). When viewed using a magni-
fied real-time video stream of the microfluidic chambers, within 10 seconds
the first of the tagged MCF7 cells can be seen to exit the focusing channel
(Fig. 3.2) and are then deflected by the magnetic field into the designated
capture chamber. Within 1 minute the first MCF7 target cells are routed
to their designated capture area. The remainder of the particles (untargeted
red and white blood cells, beads and the remaining tagged cells) continue
to sediment down the chamber to their respective capture areas (Fig. 3.1c);
within 10 minutes the separation is completed.
As shown in Fig. 3.3 and described in chapter 3.3.2, the centrifugo-
magnetic stopped-flow system very accurately and reproducibly separates a
very small number of target cancer cells from a background of a whole blood
down to concentrations as low as 1 cell per µl. Furthermore, the system can
also very efficiently segregate the unbound background beads without error-
prone steps such as size filtration. This removal of the unbound beads is of
critical importance for the quantification of the captured cells, as, otherwise,
their presence in the target chamber would influence the level of packing
measured.
60
Figure 3.2: Image obtained of bulk blood cells travelling radially outward
while a magnetically tagged cancer cell is additionally deflected by a later-
ally placed magnet. The yellow line shows the path taken by the tagged
cancer cell which is circled in yellow. Image is taken at the enterance to the
separation chamber (See Fig. 3.1 c)
3.3.2 Detection and quantification
In order to engineer a low-cost and easy to use system, we obviated the need
for any complex procedure and costly fluorescence imaging. Unlike many
other published instrumentation [60, 63] the specificity of detection in our
system is not based on the binding of a specific fluorescent antibody, but
rather on the specificity of the magnetic beads to the target cells of interest.
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As these cells are isolated from the background sample, and specifically di-
rected to a dedicated detection locus, our here presented detection technique
is based simply on analysing the extent of occupation of this locus using
bright-field imaging (Fig. 3.3a).
Figure 3.3: a) Bright-field image showing the magnetically tagged MCF7 cells
in the capture chamber. This method was used for counting the dark pixels
(tagged MCF7s) with the freeware ImageJ (See Fig. 3.4). b) Fluorescent
merge image displaying the same magnetically tagged and NucBlue stained
MCF7 cells in the capture chamber. This method was used to enumerate
the amount of MCF7 cells present in the entire system, including any cells
which did not reach the capture chamber in order to calibrate the system.
Chamber width: 150µm
The dark areas shown represent clusters of target cells surrounded with
magnetic beads which are tightly packed by the centrifugal field. The dark-
ness of the filling arises from the bead tags, and this facilitates simple image
processing to quantify the extent of packing. The surface area of the pack
was found to be directly proportional to the (pre-defined) concentration of
tagged cells in our spiked sample (Fig. 3.4). In order to quantify the exact
number present for calibration purposes we fluorescently labelled the MCF7
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cells with NucBlue dye beforehand (Fig. 3.3b). Note that for the later anal-
ysis and quantification, only the bright-field images were used.
Figure 3.4: The area of the capture chamber occupied by dark pixels was
calculated on ImageJ software and plotted against the total number (deter-
mined by fluorescent tagging) of MCF7 cells in the sample, giving a very
close linear fit (R2 = 0.98 and n = 5). This standard curve gives a baseline
calibration to determine the concentrations of target cells present based on
determination of the dark area.
We analysed the bright-field images of the target cell capture chambers
of all structures on the disc. Due to the high contrast of the cell / bead pack
with respect to the background in the capture chambers, a straight-forward
method as part of the freeware image analysis software ImageJ (ImageJ, U.S.
National Institutes of Health, MD, USA) could be employed to enumerate the
number of dark pixels in a pre-defined region of interest, and thus measure
the extent of packing within each sample. In brief, the background signal
defined a threshold value and the image was converted to an 8-bit binary
picture. The histogram could then be adjusted to provide the maximum
contrast between the dark bead / cell clusters and the bright background.
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This gave a clear count of only the black pixels and widely suppressed noise
from untagged blood cells or other stray particles. A set of six discs, with
each running five identical samples, was analysed using this method.
Figure 3.5: The total amount of MCF7 cells present in the chip is indicated
in white, while the total number captured successfully is indicated in black.
The mean recovery rate (indicated in red) is 80% (n = 5), peaking at 88%
at the highest concentration.
The total amount of MCF7 cells present in each of the whole blood tests,
and the corresponding area calculated by the dark packing fraction method
are shown in Fig. 3.4. The correlation between packing area and known
input is demonstrated by the standard curve of the graph. These estimated
values correlated directly with the actual values shown in Fig. 3.5, while the
analysis strategy successfully identified the healthy sample (i.e. zero cancer
cells) and also correctly assigned the values to the increasing concentrations
of cancer-cell spiked samples that were as low as a single MCF7 cell per µl
of whole blood sample. The capture efficiency, i.e. the ratio between the
number of cancer cells retrieved after centrifugo-magnetic purification vs the
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total number of cancer cells introduced into the chip, is 80% on average,
peaking at 88% for the highest concentration (Fig. 3.5).
3.4 Conclusions and outlook
We have presented the centrifugo-magnetophoretic purification and bright-
field based quantification of rare cells from whole blood. A test on 3µl of
sample in each chamber rapidly completes within ten minutes on our lab-
on-a-disc system; the first target cells are even detected in less than one
minute, which might be beneficial if the sheer presence of the diagnostic tar-
get cell was relevant (e.g. in the case of circulating tumour cells). The mean
recovery ratio of the target cells was 80%, peaking at 88% towards higher
concentrations. The target cell population can be quantified by a low-cost,
bight-field opto-mechanical setup incorporating a spindle motor and a CCD-
based readout akin to an optical disc drive like a CD or DVD player. We
also note that this system could detect cells at a much lower concentration
than here presented if the sample was purified and concentrated prior to the
centrifugo-magnetophoretic procedure, e.g. by band extraction of the buffy
coat or lysis of the erythrocytes. It is also worth noting that while EpCAM
was used in these particular experiments, any target (or combination of tar-
gets) can be used through adoption of widely recognized bead technologies
and bead-binding chemistries. Our system may thus be readily advanced to
a compact, rapid, accurate and fully automated sample-to-answer (rare) cell
counter for point-of-care diagnostics.
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Chapter 4
Centrifugal
Diamagnetophoresis
4.1 Preamble
As the research into detection of CTC’s advanced, it became clear that it
was important to develop technologies that were not only based on posi-
tive epitope expression, as not all CTC’s could be found in that fashion.
Size based and negative selective methods were also seen to be of impor-
tance when developing a device capable of detecting CTC’s [76, 77]. As a
side-project to the original research track, it was envisaged to try to adapt
the centrifugal microfluidic platform to perform negative magnetophoresis.
That is, magnetically removing all the healthy blood cells and leaving behind
all the cells which did not express the well known white blood cell surface
markers CD45 and CD15 and thereby isolating possible CTC’s based on their
absence of a specific marker. This work was published by Glynn et al. [78]
with experimental assistance by the author. Subsequent investigation into
negative selection methods by the author led to the next section of this work,
a method of label free, size and density based separation of pseudo cells by
centrifugal diamagnetophoresis which is outlined in this chapter.
67
4.2 Introduction
In order to expand the scope of the centrifugal magnetophoretic stopped-flow
platform to enable label-free, size and density based separation of cells it was
necessary to think about alternate methods of separating candidate CTC’s
from a blood background. As opposed to the negative magnetophoresis ex-
plored by Glynn et al. and the paramagnetic deflection discussed in chapters
1-3, it was proposed that, with a very similar set-up as before, it would be
possible to exploit the centrifugal magnetophoretic platform to enable dia-
magnetic deflection of particles AWAY from a magnet, if the particles were
suspended in a paramagnetic liquid. This method had many advantages and
was explored as a possible label free sorting technique for cells based on ei-
ther a mass, size or density difference. These property differences would in
turn effect the magnetic deflection force AWAY from the magnets and the
centrifugal force, thus resulting in diversion of particles to different capture
chambers depending on their properties. Another advantage was the fact
that a particle attracted towards a magnet will feel a rapidly increasing mag-
netic force (with a r3 relationship) that can easily cause a particle to be very
rapidly snapped towards the magnet and trapped. However, a particle being
pushed away from the magnet will not suffer this effect and will undergo a
much gentler deflection.
4.3 Theory
Most materials fall into the three main categories of magnetism. They are
either paramagnetic, ferromagnetic or diamagnetic. A typical permanent
magnet is ferromagnetic, a piece of iron which can be magnetised when in
the presence of an external magnetic field is paramagnetic and most materials
thought of as “non-magnetic” are in fact slightly repelled by a magnetic field.
These last class of materials are “diamagnetic”.
There are of course many sub categories and exceptions to this rough
categorisation, but it is not necessary to go into any more detail for the
scope of this work.
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Figure 4.1: Magnetic field simulation (FEMM, USA). When in the presence
of a magnetic field, a paramagnetic particle will be attracted towards the
magnetic field maximum (left). Whereas, a diamagnetic particle will be
pushed away from the magnetic maximum (right). This force is greatly
increased if the diamagnetic particle is suspended in a paramagnetic liquid.
4.3.1 Pseudo cells
As in previous chapters, polymer beads were used to simulate various proper-
ties of cells to prove the principle before moving on to true biological samples.
The pseudo cells in this case were 10µm polymer beads of varying densities,
full details of which are given in the materials and methods section of this
chapter. If a separation could be carried out based on slight density varia-
tions of beads, it was hypothesised that blood cells and cancer cells could be
deflected to different regions on the disc as before, but in a label free fashion,
purely based on density.
4.4 CTC detection
It has been shown that CTC’s can be identified based on their slight size and
density differences compared to normal blood cells [76, 79]. According to
the work of Liang et al. the diagmagnetic force increases with the diameter
of the particle suspended in a paramagnetic medium [80]. The sedimenta-
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tion velocity of a particle will also be affected by particle size and density,
as outlined in chapter 2.3.1. To this end it should then be possible to sort
cells based on their size and density and therefore to identify CTC candi-
dates in a label free fashion. While diamagnetic deflection of particles had
been undertaken before [80], it was believed that the unique properties of
the stopped-flow centrifugal system could offer a more accurate and less flu-
idically complex system that would enable subtle differences in size, density
and shape of the target cells to be identified. In order to investigate the vi-
ability of a centrifugal-microfluidic diagmagnetic deflection system, a series
of experiments were carried out on various different paramagnetic mediums
and particles of varying size, mass and density.
4.5 Materials and methods
4.5.1 Disc manufacture
Discs were manufactured through the standard soft lithography technique
used throughout the previous chapters. The main difference between this
design was the location of the magnets on the opposite side of the separation
chamber and the creation of the 10 finger structures at the end of the chamber
to enable the final location of the beads to be accurately determined. The full
disc schematic can be seen in figure 4.1 and a detailed view of an individual
chamber can be seen in figure 4.2.
Once the discs had been prepared for degas flow as outlined in chap-
ter 2, they were primed with the paramagnetic medium. This was either
a water based ferrofluid (Liquids Research, UK #MJ300) or the param-
agnetic salt, Manganese chloride(MnCl2) (Sigma Aldrich, USA). The fer-
rofluid was diluted at a ratio of 1:10 with a buffer of Phosphate buffered
saline with 5% w/v of Bovine serum albumin and vortexed for 5 seconds.
This made the ferrofluid light enough to be visualised through standard mi-
croscopy after the tests were performed while maintaining a high enough
magnetic susceptibility to enable significant deflection of the diamagnetic
particles. The paramagnetic salt was made up to a concentration of 1mM
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Figure 4.2: A PDMS disk of the same size as those used in all previous
chapter was made with 6 identical chambers that had magnets located on
the opposite side of the chambers as before. This was to implement the
diamagnetic pushing force on the particles entering the chambers. Full details
can be seen in Fig. 4.2.
in a buffer of Phosphate buffered saline with 5% w/v of Bovine serum albu-
min and sonicated for 5 minutes before vortexing for 30 seconds to ensure
the salt had fully dissolved into the buffer. The three types of beads used
were polystyrene (Microparticles GmbH, DE. #PS-FB-B1407 ρ = 1.05g/cm3
d=9.55µm), Polymethyl methacrylate (PMMA)(Microparticles GmbH, DE.
#PMMA-R-B1073 ρ = 1.19g/cm3 d=9.57µm) and melamine resin (MF)
(Microparticles GmbH, DE. #MF-FITC-L824 ρ = 1.51g/cm3 d=10.60µm).
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Figure 4.3: Diamagnetic deflection on the centrifugal platform. As diamag-
netic particles were sedemented through a paramagnetic medium by the cen-
trifugal force, they were deflected laterally AWAY from the magnets and into
one of the ten capture “fingers”. And example of a particle trajectory can
be seen in orange.
4.6 Results
Once the discs were primed with the chosen paramagnetic liquid, a suspension
of beads was loaded onto the disc. As in the previous chapters, 3µl of sample
was loaded into each chamber. Each sample was spun at a frequency of
17.5hz and the results for each bead in the prepared ferrofluid are outlined
below.
The final location of the three types of polymer beads are outlined below
in Fig. 4.4 and the relevant capture statistics for each are given in the
following three figures. Take note of the numbering system for each finger to
compare the capture statistics to the schematic in Fig. 4.4.
After successful enumeration of the capture efficiency of the beads in the
ferrofluid, it was important to prove the principle in the paramagnetic salt, as
if the system was to move onto using biological samples the ferrofluid would
not be a viable option, being toxic to cells. While due to time constraints it
was not possible to perform the paramagnetic salt experiments to the same
level of completion as done for the ferrofluid, the concept was proven and
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Figure 4.4: The final location of the majority of each bead type is indicated
above. The most dense particles (MF) were located in finger 1, having un-
dergone very little deflection. The medium density particles (PMMA) were
located in finger 10, furthest from the magnet, having undergone a significant
deflection. The lowest density particles (PS) were mostly located against the
chamber wall, having undergone a very large deflection and remaining pinned
against the wall by the magnetic force.
deflection of polymer beads in the MnCl2 liquid can be seen below in figure
4.8.
4.7 Conclusions and Outlook
It was shown in this work that it is possible to use the centrifugal magne-
tophoretic platform to separate with a very high accuracy, polymer micropar-
ticles with slight variations in density. And furthermore, this separation is
carried out by a diamagnetic deflection, away from the magnet. This gentle
pushing force is of great interest for implementation on a biological sample
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Figure 4.5: Final location of PMMA beads after deflection in 0.1x ferrofluid.
Over 99% of the beads were located in finger 10, furthest away from the
magnet. N=6
such as spiked cancer cells in whole blood, to laterally separate and hence
detect any cells which vary in density with those of normal healthy blood
cells.
74
Figure 4.6: Final location of MF beads (highest density) after deflection in
0.1x ferrofluid. Over 60% of the beads were located in finger 1, with a small
spread across the rest of the fingers N=6.
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Figure 4.7: Final location of PS beads (lowest density) after deflection in
0.1x ferrofluid. Over 60% of the beads were located against the chamber
wall furthest away from the magnets (seen in red) this is due to the increased
lateral displacement vector keeping them pinned against the wall. N=6
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Figure 4.8: Diamagnetic beads in a paramagnetic medium being deflected
AWAY from a magnet.
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Chapter 5
Application of the Centrifugal
Magnetophoretic Platform for
HIV/AIDS Diagnosis
This findings in this chapter have been published as:
Centrifugo-magnetophoretic purification of CD4+ cells from whole
blood toward future HIV/AIDS point-of-care applications,
Macdara Glynn, Daniel Kirby, Danielle Chung, David J. Kinahan, Gregor
Kijanka and Jens Ducre´e,
Journal of Laboratory Automation 19 (2013) 285-296.
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The technology that was developed in chapters 2-4 for circulating tumour
cell detection was also seen to show promise for many other applications,
and a HIV/AIDS diagnostic was developed. The experimental work was
conducted in tandem with Macdara Glynn. Glynn was the main author on
the publication and a more thorough explanation of the work can be found
therein. The concept was almost identical to the previous chapter, however it
has been included to highlight the fact that the centrifugal magnetophoretic
platform can be easily modified to fit a host of biomedical applications and is
here shown to perform an actual diagnostic test for HIV/AIDS without need
of sample enrichment. This is an example of centrifugal magnetophoresis
being used for abundant cell capture, as opposed to rare cell capture.
5.1 Introduction
HIV/AIDS diagnostics are of particular importance in resource-poor regions
such as Sub-Saharan Africa where as well as rates of infection being amongst
the highest in the world, access to modern laboratories and medical care are
not widespread. Point of care tests have been shown to be vitally important
in this setting to increase chances of survival and quality of life [81, 82]. Many
point-of-care devices have been developed for this very purpose and it is a
currently expanding field with new products being conceived and coming
to market since 2009. An extensive review of the field has recently been
published [83].
This chapter will offer a brief overview of the use of the system for a
HIV/AIDS diagnostic, but the full details can be found in Glynn et al.’s
publication [84].
5.1.1 HIV/AIDS
The human immunodeficiency virus (HIV) and acquired immune deficiency
syndrome (AIDS) are diseases of great concern worldwide and especially in
Sub-Saharan Africa. The standard method of testing for HIV/AIDS is to
count the concentration of a subsection of white blood cells in a patient blood
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sample. These cells are called T-helper cells, but are often refered to as “CD4
cells” due to the CD4 epitope on their surface. In a healthy patient, these
CD4 cells will be present at a rate of about 1000/µl,in a HIV positive patient
the concentration will have fallen to about 500/µl whereas a patient with full-
blown AIDS will have a concentration of less than 200/µl. The world health
organisation have recommended that any patient with a CD4 count of less
than 350/µl should immediately commence antiretoviral therapy to prevent
HIV developing into AIDS [85]. Compared to the search for CTC’s in blood
(<1CTC/µl), these parameters were significantly easier to satisfy and offered
an easily transferable use for the centrifugal-magnetophoretic platform.
5.2 Working Principle
The working principle is almost identical to the CTC diagnostic in chapter
three, with two main differences. The target epitope on the cells of interest is
different and the target cells are far more abundant than CTC’s. This meant
a change in magnetic beads to Dynabeads CD4 4.5µm magnetic beads (Life
Technologies) so that the new target epitope could be bound.
Blood was extracted directly from healthy donors via finger prick using
1.5 mm sterile lancets (BD Biosciences, Franklin Lakes, NJ) and was then
spiked with cultured CD4 cells at increasing concentrations in the medically
relevant regime.
5.3 Results
The system easily differentiated between a blood sample spiked with CD4
positive cells and CD4 negative cells, with 92% of the CD4+ cells being di-
rected to the capture chamber and only 0.6% of the CD4- cells being directed
to the capture chamber. This enabled levels of CD4+ cells in the sample to
easily be determined.
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Figure 5.1: i) Schematic of the lab on a disc platform which is almost identical
to that used in previous chapters. The magnet positioning has been adjusted
to the optimal positioning for CD4 bead and cell capture. ii) Photograph
of the capture chamber. Only the centre magnet (M2) was used during
experiments. iii) A magnetic simulation giving the approximate field strength
at various positions in the separation chamber was carried out for the new
magnet configuration (Finite Element Method Magnetics (FEMM) 2010.
5.4 Conclusion and Outlook
If this technology were combined with the cell counting technique used in
chapter 3 then a quantitative cell count could be performed to determine the
concentration of CD4+ cells blood and hence deliver an actual HIV/AIDS
diagnostic. This was the intended follow-on from this work and ultimately
led to the development of a hand-held CD4 chip by Glynn et al. [86]. This
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work all originated from the first inception of the centrifugal-magnetophoretic
platform and is an excellent example of the many possible applications of this
technology.
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Chapter 6
Large Volume Blood Handling
The previous chapters have only worked with volumes far too low to ever
be of any clinical significance (3µl per chamber) for a CTC detection device
[7, 8, 77]. This chapter discusses the necessary steps taken and the results
obtained after the move from handling approximately 3µl of sample on the
magnetophoretic cell separation platform to handling 0.2ml of sample. The
limit of detection was also improved upon as compared to chapter 3, where
1 cell/µl was the limit, to a limit here of 0.1 cells/µl. This almost two order
of magnitude increase in sample volume along with a one order of magnitude
improvement in the limit of detection allowed the device to move from a basic
proof of principle platform towards becoming a viable method of finding real
CTC’s in a patient sample.
6.1 Introduction
In order to load a blood sample of sufficient volume to enable clinically rele-
vant amounts of blood to be analysed, it was envisaged that a loading struc-
ture that was located at the centre of the disk which would simultaneously
sediment the sample through all 6 microfluidic chambers at once would offer
the best chance of high-volume throughput (Fig. 6.1).
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Figure 6.1: Schematic of the high volume design with the 3D printed centre
mould (red) enabling multiplexing of the large volume blood sample through
all six chambers simultaneously. Disc diameter=100mm
The unique benefits of centrifugal microfluidics were once again made
apparent as the centrifugal force, acting from the disc centre would simulta-
neously sediment any particles outwards in all directions (Fig. 6.2).
6.2 Materials and Methods
6.2.1 Disc Design
The disc designs mentioned in chapters 2 and 3 were never going to be able to
detect a CTC at a realistic concentration [7] because of the volume constraints
present due to the loading chamber size and manufacturing techniques used
(photolithography). It was necessary to completely redesign the disc using a
multitude of manufacturing methods in order to achieve the necessary macro
to microfluidic stopped-flow network. This was done through a combina-
tion of photolithography, 3D printing and both red and clear PDMS casting
resulting in the final design, seen in figure 6.1.
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Figure 6.2: Due to the fact that the centrifugal force acts evenly in all di-
rections from the centre it is possible to deliver the sample simultaneously
down each of the 6 chambers located at each point of the star with great
accuracy and without any flow-rate variation that might occur in a pumped
or flow-based system .
The first step was to design a central reservoir that would enable the un-
hindered passage of cells and beads from the macro-sized central unit down to
the microchannels which constituted the magnetophoretic section of the disc.
After several iterations of designs (Solidworks, USA) of varying shapes and
sizes a 6 pronged “starfish” inspired design was chosen (Figs. 6.1 and 6.2) .
The gently sloping edges and sharp corners ensured that clogging or trapping
of cells and beads was kept to an absolute minimum while they were moved
from centre to edge. The method of manufacture of this disc was to once
again be in PDMS which was necessary to form the small channels needed as
well as to enable the degas driven flow that is necessary to fill the chambers
for the stopped-flow system. However, purely photolithographically man-
ufactured channels would not be possible as the height dimensions of the
central reservoir were orders of magnitude too large. The chosen manufac-
turing technique for this part was 3-D printing (Uprint, USA). 3D printing
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enabled the rapid prototyping of several different designs and enabled cre-
ation of structures of sufficient size and resolution for our purpose. A method
of integrating the 3D printed part with the photolighograpically constructed
section was then developed and can be seen in figure 6.3.
Figure 6.3: a) The 3D printed magnet positioning mould is seen on the left
(white), while the photolithographically manufactured master with the ad-
hered 3D printed central structure (black) is on the right. b) After being
mounted on top of the master via the alignment pins, the PDMS can now
be poured to form the negative of both 3D printed moulds and the pholi-
tithographically formed microchannels. c) The completed PDMS disc, being
loaded with a blood sample. Visualisation of chambers is clearer in fig 6.1.
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6.2.2 Integration of 3D and photolithography for PDMS
casting
Simple adhesion of the 3D printed part to the photolithographically con-
structed master was not favourable due to the irreversible nature of the bond
and the propensity for damaging or at least contaminating the master with
overspill necessary to ensure the whole bottom surface formed a tight seal
with the master below.
Instead, a method of bonding with red PDMS was developed. This turned
out to be ideal as red PDMS could also be used to coat the part to give a
smoother finish and to reduce any adhesion of the clear PDMS to the 3D
printed part during the curing process as red and clear PDMS do not bond
to each other once one is cured. Red PDMS was mixed with curing agent
at a ratio of 10:1. A small amount of red PDMS was applied to the bottom
surface of the 3D printed part. The part was then placed onto the centre of
the master and adjusted until it lined up perfectly with the SU-8 structure
below it. The whole structure was then put in an oven at 70◦C for 15 minutes
to allow the red PDMS to fully cure. A reversible bond was now formed
between the master and the 3D printed part. Any excess red PDMS could
also be easily trimmed away with a scalpel blade and would easily peel away
from the surface. The bond between the 3D-printed part and the master was
robust enough to last for over 100 casts but could easily be broken by simply
twisting the part. This enabled new 3-D printed designs to be tested without
having to construct a new master, which would have been significantly more
time consuming.
A 3D printed jig was also fabricated to allow the disc to be loaded on the
motor as it could not have a centre hole, like the previous designs. This jig
enabled the disc to be held from the outside of the disc and then centrifugally
spun.
6.2.3 Binding of beads and cells
The same principle of binding of anti-EpCAM functionalised magnetic beads
to MCF7 cells spiked into blood described in chapter 3.2.3 was used to prove
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the functionality and determine the efficiency of the device before any patient
sample could be tested. However due to the increased sample volume there
were some slight differences. Blood was extracted from the arm of a healthy
donor into a 3ml BD EDTA vacutainer (Becton, Dickinson and Company,
USA). 200µl of the blood was placed into an eppendorf tube. 5µl of anti-
EpCAM functionalised magnetic dynabeads (CELLection, Epthelial enrich,
Dynabead) and the required concentration of MCF7 cells were added to the
blood sample. The sample was then incubated for 20 minutes on a rotator
at room temperature. The sample was now then ready to be loaded onto the
disc for centrifugation.
6.2.4 Loading procedure for “starfish design”
In order to facilitate an efficient and effective loading of sample into the cen-
tral loading chamber it was necessary to devise a new method of introducing
sample into the system. In chapters 2 and 3, loading was done in a loading
chamber that had a vent and an inlet. The vent could not be upstream of
the inlet or flow could be induced during rotation. To that end, the vent
was located at the same radial position a few milimetres away from the inlet.
This led to a not insignificant amount of sample being lost by travelling back
up the vent during loading. This was accepted as systematic loss. However,
this problem was rectified in this design. The idea was to have no vent, only
one loading hole (Fig 6.3 c). Once the disc had been filled with buffer by
degas flow it was necessary to load the 200µl blood sample. In order for this
to happen, 200µl l of buffer would have to be removed.
To facilitate a sample loading procedure that minimised loss and intro-
duction of bubbles, the loading procedure outlined in Fig 6.4 and visible in
Fig. 6.3 c) was carried out.
6.3 Experimental procedure
Once the central loading chamber was filled with the blood/bead/cell mixture
it could be placed on the motor and spun at the required spin frequency.
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Figure 6.4: The loading procedure which can be seen in figure 6.3 c) is
outlined here. a) A P1000 pipette tip was wedged into the 1mm diameter
inlet in the central reservoir. b) A positive pressure is applied by depressing
the “bladder” type structures near the edge of the disc, causing buffer to flow
up the pipette tip. c) The buffer the tip is replaced with the blood sample.
d) The “bladder” structures are released and a negative pressure draws the
blood sample back into the loading structure, refilling it for stopped flow
sedimentation.
After several iterations of different spin frequencies which resulted in large
losses of target cells, or contamination of the capture chamber with blood
cells due to turbulent effects caused by the increased rate of mass transfer
into the chamber (Discussed in more detail in “turbulence problems” section)
the optimum frequency was found to be 17.5hz.
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6.3.1 Issues with turbulence
One problem that immediately became apparent with the almost 2 orders
of magnitude increase in volume was the fact that millions more cells and
beads were having to travel down the focusing channel and into the separation
chamber than during the experiments in chapter 3. This was detrimental to
the stopped flow nature of the device as it caused a turbulent flow to be
initiated in the channel. Briefly, whenever a particle passes from the centre
towards the edge of the disc through the stationary liquid, it must displace
a certain volume of that liquid, dependent on its own volume. This effect is
negligible in the lower volume systems discussed in chapters 2 and 3. It even
slightly helps to enhance the system by offering some slight particle focusing
effects on the blood entering the channel (See Fig. 3.2) due to a very slight
backflow of the displaced liquid. However, when the amount of mass (cells
and beads) entering the separating chamber becomes too high the amount
of “backflow” becomes distruptive to the sedimentation of the particles and
can cause turbulence and dispersion. This led to the defined limit of 200µl
of blood being loaded in the central chamber and the optimal spin speed of
17.5 Hz being determined so as to minimise the turbulent effects caused by
the large amount of cells sedimenting through the system at high speed.
6.3.2 Centrifugation
As already highlighted in the introduction, this design was chosen to utilise
the fact that the centrifugal force acts equally in all radial directions from
the centre of the disc. This allowed the sample (in this case blood, beads
and cells) to be sedimented uniformly through all chambers on the disc si-
multaneously. This method of moving the sample from centre to edge while
passing all six magnetophoretic chambers can be clearly be seen in Fig 6.5.
This was a 200µl blood sample containing MCF7 cells and magnetic tag-
ging particles that was loaded into the centre of the disc by the method out-
lined in experimental procedures section below. It was then spun at 17.5hz
for one hour to allow the full sample to sediment through (However, the
magnetic particles are captured in a matter of minutes).
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Figure 6.5: Photo of the high volume “starfish” design before and after rota-
tion at 17.5hz. The blood sample has travelled from the centre, right to the
edge, undergoing stopped-flow magnetophoresis in each chamber simultane-
ously.
6.4 Results
Since this system was able to process 200µl of blood, it was possible to de-
crease the concentration of spiked MCF7 cells significantly to significantly
more realistic patient volumes [7] now that the disc was able to handle 200µl
of blood. The system was found to reliably detect MCF7 cells spiked into
blood at concentrations from 100 cells/µl right down to 0.1 cells/µl. A visu-
alisation of this in one of the capture areas with fluorescently tagged MCF7
cells that were spiked into a 200µl blood sample at a concentration of 1 cell/µl
is seen in Fig. 6.6 which outlines the proof of principle of the successful cap-
ture of these spiked cells while the more detailed data is presented in Fig 6.7
and 6.8.
The graphs in Figs 6.7 and 6.8 display the number of MCF7 cells detected
on discs against the original spiked concentrations.
Fig. 6.7 shows the cells captured at the lower concentrations, while Fig.
6.8 includes a sample with a much higher concentration, to see if the linear
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Figure 6.6: Microscope image of captured MCF7 cells in one chamber of the
“starfish” disc. This demonstrated that the system was able to be loaded
with 200µl of blood that had been spiked with MCF7 cells at a concentration
of 1 cell/µl and successfully detect the spiked cells.
relationship was maintained. An excellent linear relationship was shown in
both cases.
6.5 Conclusions and outlook
An increase of sample volume of almost 2 orders of magnitude to 0.2ml by
integrating several manufacturing techniques and a limit of detection im-
provement of one order of magnitude over the initial work in this thesis was
shown for a centrifugal magnetophoretic stopped-flow lab-on-a-disc platfrom.
Detection of spiked cancer cells from blood was now being done at the high
end of the clinically relevant spectrum, and on a novel and simplistic mi-
crofluidic device.
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Figure 6.7: Graph showing the capture of MCF7 cells at three different
concentrations in 200µl of blood. A clear linear relationship can be seen
with an R2 value of 0.995. The limit of detection in this case is an order of
magnitude lower than the system in chapter three.
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Figure 6.8: A higher concentration of 100 MCF7 cells/µl was also included
to see if the linear correlation continued. A clear linear relationship can be
seen with an R2 value of 0.99. This shows a highly reliable system for a
whole range of cell concentrations in a 200µl blood sample.
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Chapter 7
Density Based Blood Cell
Enrichment in a Stopped-Flow
System
This chapter is based on the following publication:
Continuous, stopped-flow separation for integrated blood cell en-
richment and analysis on centrifugal microfluidic platforms
Daniel Kirby, Claire O’Connell and Jens Ducre´e,
Proceedings of the 4th European Conference on Microfluidics - Microfluidics
2014 - Limerick, Ireland. December 10-12, 2014.
97
As a solution for solving the volume problem for CTC detection, it was
envisaged to develop a method of isolating mononuclear cells (white blood
cells, CTC’s or spiked cancer cells) from red blood cells as a form of on-disk
sample enrichment on a stopped-flow platform. The proof of principle was
proven with polystyrene beads as with the previous chapters.
Separation of microliter volumes of blood into its constitute parts is
widely needed for many biological assays. This work focuses on a simple
method of separating pseudo-white blood cells (PWBC’s) from pseudo-red
blood cells (PWBC’s) based on density in a stopped-flow centrifugal platform
and routing the separated PWBCs to a dedicated capture chamber. The ini-
tial inspiration for this idea came from a publication by Haeberle et al. where
plasma was extracted from blood in a flow-based centrifugal platform [34].
However, in keeping with the stopped-flow theme of this thesis, the work
described in this chapter is carried out without any fluid flow in the system,
and is designed to allow for isolation of WBC’s, not plasma. Polystyrene
microbeads of different densities are used as biomimetic WBCs and RBCs.
A separation of these pseudo cells was then performed in a stopped-flow
centrifugal microfluidic disc (Fig. 7.1). After several iterations of chamber
geometry, the separation was achieved by using a rounded separation unit
that allowed the less dense polystyrene beads to be pushed radially inwards,
layer by layer on top of the more dense red beads until they overflowed into
a PWBC capture chamber. The purity of WBC-mimicking beads in the cap-
ture chamber was 97-99%. However with further testing and optimisation of
the separation unit design this could be improved. If this disc design was
tested with real blood samples and proved successful in separating RBCs
from WBCs, then this simplistic separation unit could be a useful tool when
WBC counting and analysis is desired on a stopped flow system. It could
easily be incorporated into many other existing blood handling microfluidic
centrifugal discs, removing the need for complicated off-disc blood handling
processes and cutting the time it takes for blood analysis and blood based
assays.
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7.1 Introduction
Centrifugal Lab-on-a-Disc (LoaD) platforms have the innate capability of
rotationally induced sedimentation of particles and other particle handling
and analysis techniques [18]. However, once sedimented into a compacted
volume resting on the disc, these cells are hard to retrieve for subsequent steps
in an automated, multi-stage sample-to-answer cell analysis system. To this
end, a continuous particle transport strategy where the cells of interest are
permanently moving under the impact of a centrifugal field was envisaged.
Figure 7.1: Schematic of the centrifugal microfluidic platform with the X
showing the centre of rotation while the three main features of the separation
structure are indicated. Four identical chambers are present on the disk for
multiplexing.
This work outlines a new method for continuous particle separation un-
der stagnant liquid conditions through rotationally induced sedimentation.
A mixture of polystyrene microbeads (Microparticles GmbH) of two differ-
ent densities, simulating the density difference between red and white blood
cells, are driven through a stationary carrier fluid by a centrifugal field into
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a separation chamber (Fig. 7.2). This chamber exhibits a volume and ge-
ometry which is designed to retain the denser red beads while passing on a
high-purity (99%) sub-population of less-dense yellow beads to a downstream
collection chamber where they are amenable to integrated downstream anal-
ysis and/or enumeration.
Whereas WBC isolation has been shown before in flow based microflu-
idic systems [87, 88], the work presented in this chapter is of paramount
importance for developing methods of purifying blood samples in stopped-
flow centrifugal microfluidic systems such as those discussed in the previous
chapters and potential devices in the future of this under-explored field. The
stopped-flow centrifugal platform lends its self well to a density based separa-
tion technique due to the fact that cells and particles can be controlled solely
by the centrifugal field and independent of flow, unlike the vast majority of
microfluidic devices.
7.2 Theory
It is a well-established fact that when blood is placed in a centrifuge it can be
fractioned into its component parts in order of density. Our work used this
principle to develop a method of spatially separating particles of different
densities to individual chambers on a stopped flow centrifugal microfluidic
platform. The accepted values for the density of red blood cells are 1139 ±
3kg/m3 , white blood cells are 1080± 5Kg/m3 [31, 89]
As can be seen in figure 7.3, the mixture of particles will enter the separa-
tion unit from the left and more dense particles will sediment to the bottom,
while pushing the less dense particles to the top where they can over flow
to the capture chamber at a different radial position on the disk. The key
parameters which govern the efficiency of the system are the angle of the
inlet channel, the size and geometry of the separation unit and the angle at
which that structure is placed. After initial work with the basic geometry
seen in figure 6.3, the optimal geometry visible in figure 7.4 was discovered.
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Figure 7.2: Schematic of the entrance of the separation unit with relative
forces indicated for both high density beads and lower density beads. Where
(fω) is the centrifugal force, (fc) is the corialis force and (fd) is the stokes
drag. Direction towards centre of rotation is indicated by “X”.
Figure 7.3: a) Schematic of high density (red) and less dense (yellow) mi-
crobeads entering the separation unit. b) As the chamber fills, the more
dense red particles should sediment to the bottom, while the less dense yel-
low particles move to the top (or radially inward location) and overflow into
a capture chamber. c) In practice it was found that the chamber geometry
was trapping many yellow particles against the right-hand wall and leaving
many more stranded near the left-hand wall. A redesign was necessary
7.2.1 Final design of separation unit
The initial designs all ran into problems with trapping the majority of the low
density particles against the side walls. So, after several design iterations,
a curved shape with one inner side parallel to the centrifugal force vector
was found to be optimal as this allowed the denser red beads to sediment
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to the bottom while the less dense yellow beads were carried along by the
centrifugal force to a separate chamber (Fig 7.4).
Figure 7.4: Schematic of the optimal design of the separation unit which
allowed the less dense beads to freely move to the top of the more dense red
beads and escape towards the capture chamber.
7.3 Materials and methods
The discs were manufactured in PDMS, by soft lithography in an almost
identical fashion to the platforms already discussed in earlier chapters. How-
ever, in brief, the disks designs were drawn on AutoCAD (Autodesk Inc.)
and were manufactured using standard UV lithography and cast in poly-
dimethylsiloxane (PDMS). The 100mm diameter base of the disks were cut
from PMMA using a C02 laser and assembled by spin-coating the PMMA
with a thin layer of PDMS to allow for thermal bonding between the top
and bottom layers of PDMS. The two types of polystyrene particles used
were yellow 20m polystyrene particles with a density of 1.05 g/cm3 (used to
simulate WBCs) and red 20m polystyrene particles with a 20% iron core and
density of 1.88g/cm3 (used to simulate RBCs).
7.4 Results
During centrifugation, a continuous stream of particles enters the separation
chamber (Fig. 7.5). Due to their higher density, the red beads seek to
fill the separation chamber along its radially outer wall, while the less dense
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yellow beads remain on top. The continuous nature of this particle separation
(i.e. cells entering in a straight line, not a bulk migration as in a standard
centrifuge tube) prevents entrapment of the yellow beads in the stream of
abundant red beads. Due to the above mentioned factors the device gives
an extremely high purity (99%) of the yellow population (Fig. 7.6). The
percentage of yellow beads left behind in the separation unit was found to be
less than 10%. However, the design of the separation unit may be specifically
optimised for either a high yellow bead purity (by accepting by a small loss)
or a high retrieval efficiency (by accepting a slight impurity of red beads).
Figure 7.5: a) Image of mixed red and yellow beads entering the separation
unit with a lateral density gradient already visible. b e) As the chamber
fills up the less dense yellow beads are continuously pushed along the curved
edge of the separation unit towards the overflow channel, where they continue
towards a separate retention chamber. f) The input sample has been metered
to ensure that only the yellow beads will reach the overflow channel. Incorrect
metering would lead to a red bead contamination in the capture chamber.
7.5 Conclusion
Pseudo blood cells were simulated using 20m yellow polystyrene beads to
represent white blood cells and 20m red iron core polystyrene beads to rep-
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Figure 7.6: Routing of isolated yellow beads to the capture chamber with a
purity of 99%.
resent the more dense red blood cells. A separation of these pseudo cells was
then performed in a stopped-flow centrifugal microfluidic disc. The separa-
tion was achieved by using a rounded separation unit that allowed the less
dense polystyrene beads to be pushed radially inwards, layer by layer on top
of the more dense red beads until they overflowed into a capture chamber.
The purity of yellow beads in the capture chamber was 99% at a 1:1 ratio
of red and yellow beads and for the 4:1 mixture it was 97%. However with
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further testing and optimisation of the separation unit design this could be
improved. While it must be admitted that the density difference between
the red and yellow beads is significantly greater than that between red blood
cells and mononuclear cells and that the concentrations of these beads are
a long way from a real blood sample, the principle of density based separa-
tion of microparticles on a stopped-flow system was successfully shown. If
an advanced version of this disc design was tested with real blood samples
and proved successful in separating RBCs from WBCs, then this simplistic
separation unit could be a useful tool when only WBC (or CTC) counting
and analysis is desired on a stopped flow system. It could easily be incorpo-
rated into many other existing blood handling microfluidic centrifugal discs,
removing the need for complicated off-disc processes and cutting the time it
takes for blood analysis and blood based assays.
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Chapter 8
Magnetic teardrops
This chapter is based on the following publication:
Reversible imunomagnetic cell trapping and analysis on an array
of thin-film permalloy microfeatures,
Daniel Kirby, Eanna Bailey, Macdara Glynn, Charles Nwankire and Jens
Ducre´e,
Proceedings of 18th International Conference on Miniaturized Systems for
Chemistry and Life Sciences (µTAS) October 26-30, 2014, San Antonio,
Texas, USA.
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It is important to note that the work in the following chapter was carried
out “on-chip” as a proof of principle and was in fact the only work not un-
dertaken on a centrifugal platform.
Isolation and individual analysis of target cells from a bulk sample is vi-
tal in cell-based diagnostics. Previous work from Burger et.al [26] outlined
a method of trapping microparticles in a highly ordered array of geometrical
barriers, termed “v-cups”. However, any geometrical barriers, especially ones
that are highly ordered and close together are highly susceptible to clogging,
especially if there are no divergent flow lines around the barriers, as in a
stopped-flow system. The concept for the work in this chapter was to create
an array of “virtual v-cups” by patterning dots of ferrous material on the
floor of a microchannel. Upon exposure of the microchannel to an external
magnetic field, the field intensity would be increased in the areas patterned
with the ferrous material. This would create a pattern of magnetic “poten-
tial wells” where a magnetic particle or magnetically tagged cell at a close
enough vicinity would migrate to. By patterning an array of these “magnetic
dots” on the floor of a channel a barrier-free completely open channel would
be able to retain cells or particles in much the same way as the v-cups but
with no clog-causing barriers and with the possibility of releasing the cells
for downstream analysis by merely removing the external magnetic field. We
here present the magnetically controlled separation of specific target cells by
a sputter-deposited thin-film of permalloy teardrops. Apart from simplified
fabrication of our essentially 2-dimensional (160nm thick), thin-film archi-
tecture, our device also features high capture efficiencies, leaves flow lines
unperturbed, assures homogeneous reagent exposure and suppresses particle
clogging. Furthermore, the trapped cells can readily be released for further
downstream analysis by removing the external magnetic field, thus fully re-
generating the device for the next experiment.
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8.1 Introduction
Capture and analysis of individual cells from a mixed population is vital in
cell-based diagnostics. Previous work has established the ability to array
target cells using 3-dimensional geometrical obstacles such as micropillars
and cups [1]. We here present a separation device that aligns magnetic beads
and immuno-magnetically tagged target cells into an ordered grid generated
by a micropatterned, 160-nm thick permalloy film (80% Nickel, 20% Iron)
deposited on the base of the chamber (Fig. 8.1).
Figure 8.1: Magnetic bioparticles such as beads or tagged cells (red) are
retained at the tip of the teardrop-shaped magnetic dots (black) where the
local field is strongest while the unperturbed, non-magnetic particles (blue)
continue in the downstream direction.
Maxima of the magnetic field arise in the vicinity of the sharp edges of
these microfeatures, as outlined in the magnetic field simulations (Fig. 8.2).
These potential wells serve to localize paramagnetic bioparticles (within a
certain size range) such as tagged cells or beads during analysis or successive
steps of washing and reagent exposure. Going beyond the capabilities of
geometrical barriers, our trapping mechanism is inherently reversible and
can be easily adapted to suit specific particle sizes or flow conditions.
Magnetic cell isolation has become widespread, with the majority of sys-
tems using bulk magnetic forces [90]. The novelty in our system is the arrayed
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Figure 8.2: Simulation of local magnetic field for different shapes of a mi-
cropatterned permalloy film in a uniform external magnetic field. a) The
round dot delivers a rather even distribution of the magnetic field. b) The
star-shaped structure provides a larger field amplitude but it features sev-
eral maxima. c) The teardrop shape focusses the magnetic field in into a
single maximum which turned out to be optimal for capture of individual
bioparticles at high spatial definition.
trapping of the magnetically tagged cells (Fig. 8.3) where they can be stud-
ied individually and undergo media change, e.g. for fluorescent staining [26].
The thin-film nature of these traps suppresses clogging and inevitable diver-
gence of flow lines around 3D-obstacles, thus enhancing capture efficiency
and assuring uniform exposure to reagents. Following on-array retention,
the cells can be efficiently released into a downstream capture chamber by
simply removing the magnetic field.
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8.2 Materials and Methods
The permalloy features are deposited on the floor of the chip by sputter-
coating a UV-lithographically patterned (OAI, model 200) AZ-photoresist
which was spin-coated on glass slides. A PMMA lid was cut by a CO2 laser
and bonded to the glass via a pressure-sensitive adhesive featuring an 86µm
high microchannel for the passage of the cells. The MCF7 cancer cells were
incubated with 4.5µm magnetic anti-EpCAM beads before being introduced
to the system.
8.3 Results
This chip enables the separation of target bioparticles from an abundant
background into an array of magnetic traps with single-occupancy distribu-
tion (Fig. 8.3a & b). We have measured a capture efficiency of over 99% for
magnetic beads and a purity of 98.5%, with a non-magnetic particle purity
of over 99.9% in the waste chamber.
With a biomimetic sample of magnetically tagged MCF7 cells spiked into
whole blood, we have furthermore shown a capture efficiency of 100% (Fig.
8.3c) while over 99% of the background blood cells advance to the waste
chamber. We have also demonstrated media exchange without disturbing
the retention of the cells and successfully released them for downstream anal-
ysis. We have also performed size separation by the variation of micro-dot
geometry. Overall, this new and reversible magnetic alignment method of
individual cells could easily be adapted to various formats of particle-based
bioassays.
8.4 Conclusion
We have shown an immuno-magnetic method for high-efficiency, reversible
trapping of magnetically tagged target cells suspended in a biological back-
ground into an array where they can be analysed by common bioanalytical
protocols. The 2-dimensional nature of the system facilitates microfabrica-
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Figure 8.3: a) Microscope image of 20µm magnetic beads (red circle) trapped
by the local magnetic field maxima at the tips of the magnetic permalloy
teardrops while the trajectory of non-magnetic beads (blue circle) remains
unperturbed. The magnetic beads were captured with a sensitivity of 99.6%
and a purity of 98.5%. Also, 99.95% of the non-magnetic beads were routed
to the waste chamber. b) Magnetically tagged MCF7 cells were trapped on
the magnetic permalloy teardrops, formed using an OAI 200 mask aligner.
tion, suppresses issues such as particle clogging and diverging flow fields that
occur with common, 3D-geometrical obstacles and thus enhances capture
efficiency. It is in the very early stages, but if integrated into a stopped-
flow microfluidic device it could offer an attractive method of arraying and
analysing magnetically tagged cells.
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Figure 8.4: Capture of tagged MCF7 cells (circled in red) in a background
of whole blood, which is flowing past. The MCF7 cells were captured with
a sensitivity of 100%, while over 99% of the blood cells were routed to the
waste chamber.
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Chapter 9
Conclusions and future work
This thesis outlines the work undertaken towards completion of a PhD on
the topic of magnetophoretic cell handling on a centrifugal microfluidic plat-
form for rare cancer cell detection in blood. Circulating tumour cells are
currently not detectable in any standard clinical or hospital setting. Devel-
oping a system that would enable this would be a serious game-changer in
cancer diagnosis and prognosis. This work focuses on outlining from a phys-
ical, biological, clinical and engineering perspective, the development of a
microfluidic device for circulating tumour cell (CTC) detection. At first the
physical principle was shown by using bio-mimetic polystyrene microbeads
to simulate cancer cells in blood. This process began by developing a system
that could separate and detect a rare concentration of magnetic microbeads
in an abundant background of non-magnetic microbeads with an sensitivity
of over 96%. It is important to note that this was the first published case
of lateral magnetophoretic separation of particles on a centrifugal platform.
One of the key factors in the accuracy and simplicity of this technique was the
stopped-flow system which was used. Stopped-flow enables far higher levels
of control over particles’ trajectories than in a standard flow-based microflu-
idic platform which contains divergent flow lines and varying flow profiles.
Once the bio-mimetic section of the work was completed, an investigation
into using a real biological sample was undertaken. This resulted in using
magnetically tagged MCF7 breast cancer cells spiked into a blood sample
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with the understanding that they should behave in a very similar fashion
to the biomimetic microbeads. After various iterations of optimisations and
adjustments this indeed proved to be the case, and as well as successfully
capturing magnetically tagged cancer cells in a blood background at a con-
centration of as low as 1 cell/µl and with a sensitivity of over 80%, a method
of brightfield enumeration of the captured cells was also developed which en-
abled the author to easily differentiate between a healthy blood sample and
blood containing 5 different concentrations of MCF7 cancer cells.
Once this stage in the research was completed, the work could advance
towards being more clinically relevant. The first step was to redesign the
system to handle volumes on the millilitre scale, as opposed to the microlitre
scale. This required integration of various manufacturing techniques and
led to new problems in maintaining a stable stopped-flow magnetophoretic
system due to the massive increase in material being passed through the
channels. However once these new hurdles were crossed the author was able to
successfully analyse 0.2ml of blood and detect cancer cells at a concentration
of as low as 0.1 cell/µl as opposed to 1 cell/µl in a 3µl sample, which was
the maximum sample volume at the initial stage of the work. This almost 2
orders of magnitude shift in the volume capabilities along with an order of
magnitude improvement in the limit of detection of the device moved it into
the region where true analysis of clinical samples could be possible.
If this work was pushed to the next level by investigating further the
complex properties of circulating tumour cells and tailoring the capture pa-
rameters of this our system to same, then a truly bedside CTC detection
lab-on-a-disc device could become a clinical reality. This would ignite a
whole new method of dealing with cancer, moving away from costly, time
consuming and overburdened MRI and CT machines and making room for
CTC detection from blood, right at the patient’s bedside.
As well as focusing on the main topic, the author has also investigated
various other methods of magnetic and stopped flow particle control for other
purposes. This can be seen in the chapters on density based separation of
particles for blood processing in a stopped-flow environment, virtual mag-
netic traps for barrier free filtration of particles or cells based on their size
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and surface markers, and on the HIV-AIDS diagnostic that was developed
based on the original work presented here.
It is hoped that by presenting this work on the hugely under-explored area
of stopped-flow centrifugal magnetophoresis and by elucidating the many
unique benefits it has, that the field will continue to grow and build on what
has been shown in order to make great strides in the field of cell analysis on
lab-on-disc platforms for biomedical applications.
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